Bell's palsy

G6_BELLPA

Bell's palsy: Partial or complete paralysis of the facial muscles of one side of a person's face. It is caused by damage to the seventh cranial nerve. It is usually temporary but it may recur.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G51.0 Hospital discharge: ICD-9 — 3510A Hospital discharge: ICD-8 — 350 Cause of death: ICD-10 — G51.0 Cause of death: ICD-9 — 3510A Cause of death: ICD-8 — 350 2 out of 7 registries used, show all original rules.	5273
4. Check minimum number of events None	5273
5. Include endpoints None	5273
6. Filter based on genotype QC (FinnGen only)	5062

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G51
Name in latin: Paresis nervi facialis

NAME	G6_BELLPA
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G510
HD_ICD_9	3510A
HD_ICD_8	350
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G510
COD_ICD_9	3510A
COD_ICD_8	350
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bell's palsy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41280	21652	19358
Only index persons	36873	19506	17367
Unadjusted period prevalence (%)
Whole population	0.58	0.62	0.54
Only index persons	0.69	0.72	0.66
Median age at first event (years)
Whole population	51.87	52.85	50.80
Only index persons	50.32	51.08	49.47

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5062	2862	2200
Unadjusted period prevalence (%)	1.01	1.02	1.01
Median age at first event (years)	53.81	51.10	57.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5272: Matched controls
52720

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02.2

ICD-10 Finland

Lagophthalmos

53.5

317.6

181

H02AB06

ATC

prednisolone; systemic

4.7

307.7

3681

17492

G56.0

ICD-10 Finland

Carpal tunnel syndrome

8.9

307.7

551

686

ACC51

NOMESCO Finland

Release of median nerve

70.3

307.7

267

G51.0

ICD-10 Finland

Bell palsy

19220.9

307.7

4899

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

31.9

257.5

167

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

195.3

2587

15352

TAB00

NOMESCO Finland

Lumbar puncture

4.7

166.3

409

932

3510A

ICD-9 Finland

Facial nerve disorders, Bell's palsy

+∞

141.3

135

G50.1

ICD-10 Finland

Atypical facial pain

13.4

138.4

131

100

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

340.7

133.2

134

35008

ICD-8 Finland

Facial paralysis, Alia definita

+∞

132.9

127

AA1AD

NOMESCO Finland

CT of head and brain

2.2

130.2

1585

8749

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

129.5

600

2099

N91

ICPC

Facial paralysis/bell's palsy

225.6

128.4

132

G50.0

ICD-10 Finland

Trigeminal neuralgia

13.9

126.3

117

G51.9

ICD-10 Finland

Disorder of facial nerve, unspecified

197.6

111.9

116

D33.30

ICD-10 Finland

Acoustic neuroma

11.6

96.6

100

QAJ10

NOMESCO Finland

Browlift

19.7

95.7

UDC00

NOMESCO Finland

Ear microscopy

2.8

92.6

491

1840

DFF00

NOMESCO Finland

Pure tone audiometry

2.5

90.8

635

2731

N03AX16

ATC

[U] pregabalin

2.0

90.3

1179

6548

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

35.4

89.0

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.2

86.6

856

4271

35009

ICD-8 Finland

Facial paralysis, Unspecified

+∞

82.5

N03AX12

ATC

[U] gabapentin; oral

2.2

77.7

794

4002

G56.2

ICD-10 Finland

Lesion of ulnar nerve

7.7

76.4

107

141

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

18.4

75.1

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

9.3

74.0

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

72.5

1352

8366

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

69.4

1239

7550

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

69.0

563

2581

35000, ,

ICD-8 Finland

+∞

68.9

G54.0

ICD-10 Finland

Brachial plexus disorders

8.3

68.8

112

J05AB11

ATC

valaciclovir; oral

2.1

68.7

795

4186

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

68.3

1204

7303

A10AE04

ATC

insulin glargine; parenteral

2.4

67.8

521

2326

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

67.0

223

630

CBF10

NOMESCO Finland

Shortening of canthal ligaments and tarsal plate for ectropion

19.8

66.0

ZZC00

NOMESCO Finland

Graft of fascia

23.7

65.4

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

5.7

64.0

121

218

H53.2

ICD-10 Finland

Diplopia

3.5

63.9

224

655

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

18.4

63.8

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

7.2

62.6

131

A10BA02

ATC

metformin; oral

1.7

61.7

1406

9153

N02AX02

ATC

tramadol; systemic, rectal

1.6

59.4

2060

14927

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

59.2

494

2281

TAC00

NOMESCO Finland

Peripheral nerve block

15.0

58.8

R51.80

ICD-10 Finland

Headache

1.9

57.3

786

4372

H02.1

ICD-10 Finland

Ectropion of eyelid

6.4

56.3

150

A02BC02

ATC

pantoprazole; systemic

1.6

55.9

3387

27847

T90

ICPC

Diabetes non-insulin dependent

1.7

55.4

1160

7343

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

54.2

439

1999

R42

ICD-10 Finland

Dizziness and giddiness

1.7

53.8

1121

7079

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

53.2

593

3062

A10AC01

ATC

insulin (human); parenteral

2.4

51.4

386

1700

H02.4

ICD-10 Finland

Ptosis of eyelid

3.4

51.4

190

575

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

50.7

372

1622

G51.3

ICD-10 Finland

Clonic hemifacial spasm

+∞

50.1

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

49.5

319

1309

CBH25

NOMESCO Finland

Tarsorrhaphy

69.3

48.1

J01DB01

ATC

cefalexin; oral

1.7

47.8

4190

36822

A10AB05

ATC

insulin aspart; parenteral

2.3

47.7

387

1761

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

46.4

293

1191

CBN30

NOMESCO Finland

Shortening of canthal ligament

9.1

45.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

44.1

2181

16787

A69.2

ICD-10 Finland

Lyme disease

2.3

42.1

325

1446

N02BE01

ATC

paracetamol; systemic, rectal

1.7

42.1

4480

40428

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

10.5

41.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

40.7

2091

16140

A10BB12

ATC

glimepiride; oral

2.3

40.1

329

1502

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

38.7

2822

23238

N06AX21

ATC

duloxetine; oral

1.9

38.7

524

2883

H02.3

ICD-10 Finland

Blepharochalasis

2.2

38.0

325

1509

A10AE05

ATC

insulin detemir; parenteral

2.4

37.7

261

1107

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

8.1

36.7

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

5.3

36.6

142

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

36.6

3449

29674

A10BH01

ATC

sitagliptin; oral

2.0

36.2

451

2411

M79.6

ICD-10 Finland

Pain in limb

1.5

36.1

1897

14609

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

35.9

237

983

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

35.8

829

5324

G51.8

ICD-10 Finland

Other disorders of facial nerve

186.3

35.8

A10BJ06

ATC

semaglutide; parenteral

2.4

35.0

248

1062

G44.2

ICD-10 Finland

Tension-type headache

1.8

34.7

616

3677

C03CA01

ATC

furosemide; systemic

1.5

34.7

1301

9342

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

6.9

34.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

34.3

1941

15119

H02AB04

ATC

methylprednisolone; systemic

1.7

34.3

678

4173

CBF99

NOMESCO Finland

Other operation for ectropion

12.8

34.0

SPAT1262

SPAT

Handing over of treatment supplies

1.6

33.8

799

5151

G51

ICD-10 Finland

Facial nerve disorders

176.1

33.7

QAJ30

NOMESCO Finland

Other facelift

11.4

33.6

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

33.6

477

2661

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.2

33.3

211

ACC53

NOMESCO Finland

Release of ulnar nerve

56.1

33.2

J01DA01

ATC

[U] cefalexin

1.4

32.7

2953

24944

M03BX02

ATC

tizanidine; oral

1.4

32.6

2926

24677

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

32.2

559

3312

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

31.8

1667

12755

C08CA01

ATC

amlodipine; oral

1.4

31.8

1726

13293

J01AA02

ATC

doxycycline; systemic

1.5

31.3

3785

33548

R51.81

ICD-10 Finland

Facial pain NOS

3.3

31.2

120

373

M54.5

ICD-10 Finland

Low back pain

1.4

31.1

1601

12199

CBH30

NOMESCO Finland

Tarsorraphy

110.7

30.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

30.5

717

4607

J05AB01

ATC

aciclovir; systemic

1.5

30.5

1014

7069

J01FF01

ATC

clindamycin; systemic

1.5

30.0

1232

8975

N03AF01

ATC

carbamazepine; oral, rectal

2.4

29.9

215

927

QAJ20

NOMESCO Finland

Subperiosteal facelift

155.9

29.7

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

4.0

29.6

217

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

29.2

291

1434

ELB50

NOMESCO Finland

Total parotidectomy

9.3

29.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

29.1

760

5009

H02AB07

ATC

prednisone; oral

1.7

29.0

634

3996

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

28.9

748

4920

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

3.1

28.6

121

398

B02.8

ICD-10 Finland

Zoster with other complications

5.8

28.5

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

28.1

G47.3

ICD-10 Finland

Sleep apnoea

1.5

28.1

1011

7155

205

Kela drug reimbursment

Chronic hypertension

1.5

28.0

1145

8316

M48.0

ICD-10 Finland

Spinal stenosis

1.8

27.8

469

2752

Z3231

NOMESCO Finland

Registered nurse

1.5

27.8

1248

9229

S18

ICPC

Laceration/cut

1.4

27.6

2019

16280

DC1AD

NOMESCO Finland

Temporalbone CT

4.3

27.4

168

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

27.2

398

2236

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

27.1

215

967

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

27.1

998

7089

SPAT1263

SPAT

Sampling

1.4

27.0

1890

15114

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

26.9

1128

8223

AAH50

NOMESCO Finland

Cranial nerve anastomosis

75.5

26.8

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

26.7

189

809

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

26.6

1884

15080

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.1

26.6

108

H01

ICPC

Ear pain/earache

1.7

26.5

506

3073

R03AC02

ATC

salbutamol; inhalant

1.4

26.2

2520

21175

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

26.0

2424

20256

E66.8

ICD-10 Finland

Other obesity

2.1

25.9

250

1217

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

25.8

1165

8608

A10AE06

ATC

insulin degludec; parenteral

2.5

25.7

159

640

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

25.6

404

2322

R06.0

ICD-10 Finland

Dyspnoea

1.5

25.5

1158

8559

N06AA09

ATC

amitriptyline; systemic

1.8

25.4

391

2232

A02BC03

ATC

lansoprazole; oral

1.4

25.2

1236

9264

N03

ICPC

Pain face

4.8

25.2

121

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

25.1

383

2179

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

25.1

955

6817

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

25.1

253

1253

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

24.8

1252

9429

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

24.5

1624

12815

M01AH05

ATC

etoricoxib; oral

1.3

24.3

2839

24454

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

24.1

318

1728

R52.9

ICD-10 Finland

Pain, unspecified

1.7

24.0

421

2495

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

24.0

308

1660

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

6.3

24.0

R4120

NOMESCO Finland

Occupational therapy

1.9

23.9

287

1513

A10BK03

ATC

empagliflozin; oral

1.7

23.8

419

2485

ZXA05

NOMESCO Finland

Left side

1.5

23.8

1034

7566

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

23.8

171

738

N02BF01

ATC

gabapentin; oral

1.9

23.7

317

1731

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.3

23.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

23.5

263

1353

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

23.4

342

1921

ZXA10

NOMESCO Finland

Bilateral

1.5

23.4

809

5658

G53.2*D86.8

ICD-10 Finland

Multiple cranial nerve palsies in sarcoidosis

+∞

22.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

22.9

553

3564

N06AX16

ATC

venlafaxine; oral

1.6

22.9

598

3928

G35

ICD-10 Finland

Multiple sclerosis

3.2

22.9

274

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

22.7

320

1777

M01AB05

ATC

diclofenac; systemic, rectal

1.3

22.7

3084

27043

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

22.6

412

2468

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

22.5

1210

9191

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

22.5

159

681

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

22.1

2539

21694

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

3.9

22.0

161

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

22.0

809

5724

UJF32

NOMESCO Finland

Coloscopy

1.4

21.9

1118

8410

35399

ICD-8 Finland

Sciatica

+∞

21.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

21.8

947

6916

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

21.8

2179

18232

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

21.7

107

384

SPAT1301

SPAT

No procedures

1.4

21.7

1344

10451

R06AE07

ATC

cetirizine; oral

1.3

21.6

1986

16411

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

21.5

556

3640

M25.5

ICD-10 Finland

Pain in joint

1.4

21.5

1370

10695

A10BJ02

ATC

liraglutide; parenteral

2.6

21.5

127

501

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

21.4

332

1897

A02BC05

ATC

esomeprazole; systemic

1.3

21.3

1792

14604

P01AB01

ATC

metronidazole; oral, rectal

1.3

21.3

1767

14371

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

21.0

1743

14170

SPAT1153

SPAT

Removal of sutures

1.4

20.9

1317

10259

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

20.6

470

2984

A10AB04

ATC

insulin lispro; parenteral

2.5

20.5

131

536

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

20.5

471

2997

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

20.3

708

4949

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

20.2

662

4566

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

20.2

673

4658

ZXA00

NOMESCO Finland

Right side

1.4

20.1

1080

8184

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

20.0

197

967

Z3226

NOMESCO Finland

Physiotherapist

1.5

20.0

781

5582

AAE32

NOMESCO Finland

Translabyrinthine excision acoustic neurinome

57.7

19.9

160

Kela drug reimbursment

exenatide

2.9

19.8

320

C10AA01

ATC

simvastatin; oral

1.3

19.6

1763

14465

K02.1

ICD-10 Finland

Caries of dentine

1.3

19.5

2687

23376

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.4

19.4

200

T89

ICPC

Diabetes insulin dependent

2.2

19.4

166

772

B01AC04

ATC

clopidogrel; oral

1.5

19.4

655

4547

A02BC01

ATC

omeprazole; systemic

1.4

19.3

1163

8976

WX002

NOMESCO Finland

Sedation and analgesia

1.4

19.3

816

5921

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

31.4

19.2

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

19.0

267

1481

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

18.9

499

3279

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

18.8

1276

10028

CBH40

NOMESCO Finland

Division of tarsorrhaphy

+∞

18.8

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

15.9

18.8

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

18.7

142

628

132

Kela drug reimbursment

Sarcoidosis

4.7

18.6

L17

ICPC

Foot/toe symptom/complaint

1.4

18.6

1195

9306

N05CF01

ATC

zopiclone; oral

1.3

18.5

1384

11033

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

18.4

782

5676

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.5

18.2

174

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

18.0

1587

12946

109

Kela drug reimbursment

Multiple sclerosis

3.4

18.0

190

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

3.7

17.9

148

N02BF02

ATC

pregabalin; oral

1.9

17.8

227

1220

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

17.8

317

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.8

17.7

329

G51.1

ICD-10 Finland

Geniculate ganglionitis

+∞

17.7

QAJ35

NOMESCO Finland

Other correction of loose or redundant skin of head or neck

+∞

17.7

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

17.6

712

5115

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

17.6

1007

7690

M01AE02

ATC

naproxen; oral, rectal

1.3

17.6

2548

22187

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

17.5

237

1300

N03AE01

ATC

clonazepam; systemic

1.9

17.5

239

1315

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

17.4

129

566

J01MA02

ATC

ciprofloxacin; systemic

1.3

17.3

1694

14003

ZXE00

NOMESCO Finland

One hour or less

1.3

17.3

1706

14120

H62.1*B02.8

ICD-10 Finland

Otitis externa in zoster

20.9

17.3

C07AB07

ATC

bisoprolol; oral

1.3

17.2

2094

17814

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

17.2

243

1351

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

17.1

138

627

N06AX11

ATC

mirtazapine; oral

1.3

17.1

1456

11806

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

17.1

306

1824

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

16.0

17.0

ZXD05

NOMESCO Finland

Urgent procedure

1.3

17.0

1330

10653

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

16.9

952

7244

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

3.1

16.9

218

A10BJ01

ATC

exenatide; parenteral

3.5

16.9

159

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.1

16.8

114

C10AA05

ATC

atorvastatin; oral

1.3

16.8

1760

14672

A10BX04

ATC

[U] exenatide

3.6

16.8

155

S04.5

ICD-10 Finland

Injury of facial nerve

63.5

16.7

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

16.7

453

2996

ELB60

NOMESCO Finland

Radical parotidectomy sacrificing the facial nerve

+∞

16.7

EBA00

NOMESCO Finland

Extraction of tooth

1.3

16.6

1538

12602

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

16.6

160

781

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

16.5

352

2196

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

16.5

2080

17747

A02BA02

ATC

ranitidine; systemic

1.4

16.4

783

5791

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.5

16.4

105

431

R50.9

ICD-10 Finland

Fever, unspecified

1.5

16.4

625

4438

N06AB04

ATC

citalopram; systemic

1.4

16.3

880

6647

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

16.3

195

1027

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

16.3

276

1619

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.5

16.2

154

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

16.2

729

5337

N18

ICPC

Paralysis/weakness

2.6

16.2

357

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

16.1

291

1738

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

2.3

16.0

119

523

R52.2

ICD-10 Finland

Other chronic pain

2.2

16.0

141

665

L01

ICPC

Neck symptom/complaint

1.5

15.8

626

4473

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

15.8

1162

9206

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

15.8

1250

10012

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

15.7

548

3820

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

15.7

223

R51

ICD-10 Finland

Headache

1.8

15.7

225

1257

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

15.7

646

4652

N02AA05

ATC

oxycodone; systemic

1.4

15.7

686

4995

M01AC06

ATC

meloxicam; systemic, rectal

1.3

15.7

1516

12478

35002

ICD-8 Finland

Facial paralysis, Spasmus facialis

+∞

15.6

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

+∞

15.6

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

+∞

15.6

G52.9

ICD-10 Finland

Cranial nerve disorder, unspecified

85.3

15.6

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

15.5

183

961

A10BB01

ATC

glibenclamide; oral

2.1

15.4

144

694

A46

ICD-10 Finland

Erysipelas

1.5

15.4

587

4164

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

15.4

321

1993

R4110

NOMESCO Finland

Physiotherapy

1.3

15.4

1172

9331

CBD99

NOMESCO Finland

Other plastic reconstruction of eyelid

16.1

15.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

15.1

545

3826

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

15.1

1266

10212

J01CA04

ATC

amoxicillin; systemic

1.3

15.1

3899

36152

C09AA05

ATC

ramipril; oral

1.3

15.0

1015

7936

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

15.0

1546

12820

H92.0

ICD-10 Finland

Otalgia

1.7

14.9

248

1448

L86

ICPC

Back syndrome with radiating pain

1.8

14.9

229

1307

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

14.9

510

3544

Z71.8

ICD-10 Finland

Other specified counselling

1.3

14.8

1314

10673

A10AB01

ATC

insulin (human); parenteral

2.2

14.8

129

605

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

14.7

3311

30112

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.6

14.7

SPAT1260

SPAT

Consultation of another employee

1.4

14.6

707

5237

CBC10

NOMESCO Finland

Removal of foreign body from eyelid

80.3

14.6

A10BH05

ATC

linagliptin; oral

1.8

14.6

200

1103

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

14.5

259

1542

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

14.5

272

R07.3

ICD-10 Finland

Other chest pain

1.5

14.5

411

2744

N07CA01

ATC

betahistine; oral

1.7

14.5

298

1844

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

14.4

3169

28709

SFA10

NOMESCO Finland

One-surface restoration

1.3

14.4

2436

21412

J01FA06

ATC

roxithromycin; oral

1.3

14.4

1714

14454

L28

ICPC

Limited function/disability (L)

1.4

14.4

686

5069

XA402

NOMESCO Finland

ENMG

2.7

14.3

285

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

14.3

198

G53.0*B02.21

ICD-10 Finland

Postherpetic geniculate ganglionitis

27.2

14.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

14.2

984

7713

CBW99

NOMESCO Finland

Other operation on eyelid

22.3

14.2

R60.0

ICD-10 Finland

Localized oedema

1.5

14.0

475

3290

J01MA12

ATC

levofloxacin; systemic

1.4

14.0

747

5621

H16.0

ICD-10 Finland

Corneal ulcer

1.8

14.0

201

1124

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

14.0

153

783

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

14.0

594

4299

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

13.9

414

2791

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

13.9

771

5837

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

13.9

488

3405

DEB00

NOMESCO Finland

Cortical mastoidectomy

30.1

13.9

G03.9

ICD-10 Finland

Meningitis, unspecified

6.0

13.8

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

13.8

534

3795

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.5

13.8

136

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

13.8

549

3923

D33.3

ICD-10 Finland

Benign neoplasm: Cranial nerves

23.8

13.8

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

13.7

144

726

L12

ICPC

Hand/finger symptom/complaint

1.4

13.7

608

4433

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

13.7

357

2338

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.4

13.7

369

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.1

13.7

177

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

13.7

266

1622

L03

ICPC

Low back symptom/complaint

1.3

13.6

1109

8891

G61.0

ICD-10 Finland

Guillain-Barré syndrome

5.1

13.6

ZZK00

NOMESCO Finland

Graft of nerve

75.3

13.6

R52.1

ICD-10 Finland

Chronic intractable pain

3.8

13.6

105

SPAT1310

SPAT

Counselling related to known health issue

1.3

13.5

1314

10783

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.2

13.5

158

XCK00

NOMESCO Finland

Perimetry

1.7

13.5

251

1512

S29

ICPC

Skin symptom/complaint other

1.4

13.5

774

5892

M02AA07

ATC

piroxicam; topical

1.3

13.4

1480

12340

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.4

1667

14105

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

18.2

13.3

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

13.3

4402

41696

TQA05

NOMESCO Finland

Puncture of skin of head or neck

21.2

13.3

QAJ15

NOMESCO Finland

Browlift using video-endoscope

21.2

13.3

2251A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cranial nerves

21.2

13.3

J02AC01

ATC

fluconazole; systemic

1.3

13.3

1661

14057

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

13.3

330

2138

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.9

13.2

172

934

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

13.2

375

2505

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

13.1

1280

10504

C08CA13

ATC

lercanidipine; oral

1.4

13.0

557

4036

J01DA09

ATC

[U] cefadroxil

1.3

12.9

1106

8917

A10BG03

ATC

pioglitazone; oral

2.2

12.8

104

475

9560/0-C72.5

ICD-O-3

Schwannoma, NOS, of cranial nerve, NOS

50.1

12.8

C09AA02

ATC

enalapril; systemic

1.4

12.8

762

5831

L08

ICPC

Shoulder symptom/complaint

1.3

12.8

855

6658

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

12.7

222

1314

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

12.7

520

3733

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

12.7

447

3119

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

12.7

250

1530

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

12.6

373

2513

T82

ICPC

Obesity

1.9

12.6

159

855

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

12.6

999

7972

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.1

12.5

A06AD11

ATC

lactulose; oral

1.4

12.5

559

4077

G51.2

ICD-10 Finland

Melkersson syndrome

+∞

12.5

SPAT1216

SPAT

Assessment of functional ability

1.4

12.5

590

4346

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

12.5

890

6994

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

12.5

166

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.9

12.5

198

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

12.4

932

7375

R05

ICPC

Cough

1.3

12.4

964

7668

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

12.4

431

R53

ICD-10 Finland

Malaise and fatigue

1.3

12.4

979

7807

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

12.4

1624

13798

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

12.3

388

2647

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

12.2

1083

8765

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.0

12.2

179

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

12.2

455

3213

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

12.1

169

938

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.4

12.1

335

N01

ICPC

Headache

1.5

12.1

404

2791

C09CA01

ATC

losartan; oral

1.3

12.1

1040

8384

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.5

12.1

305

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

12.0

370

2512

A10BK01

ATC

dapagliflozin; oral

1.6

12.0

271

1715

R01AD09

ATC

mometasone; nasal

1.2

12.0

1953

16976

N03AX09

ATC

lamotrigine; oral

1.8

12.0

178

1007

R02

ICPC

Shortness of breath/dyspnoea

1.4

12.0

494

3553

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

12.0

604

4499

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

11.9

1110

9037

G53.0

ICD-10 Finland

Postzoster neuralgia

4.3

11.9

WX402

NOMESCO Finland

General anaesthesia

1.3

11.9

863

6793

F29

ICPC

Eye symptom/complaint other

1.5

11.9

371

2528

CBK99

NOMESCO Finland

Other operation for retraction of eyelid

46.8

11.9

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

11.9

1107

9017

M54.2

ICD-10 Finland

Cervicalgia

1.6

11.8

294

1906

Z2445

NOMESCO Finland

Psychologist

1.9

11.8

151

816

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

14.7

11.8

A10BX07

ATC

[U] liraglutide

3.0

11.8

172

H46

ICD-10 Finland

Optic neuritis

3.2

11.7

141

R13

ICD-10 Finland

Dysphagia

1.6

11.7

269

1710

DEB30

NOMESCO Finland

Radical mastoidectomy

10.5

11.7

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

8.9

11.7

H57.1

ICD-10 Finland

Ocular pain

1.9

11.7

147

789

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

11.7

181

1037

SFA30

NOMESCO Finland

Three-surface restoration

1.2

11.6

1799

15540

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

11.6

114

562

AAE34

NOMESCO Finland

Other operations on acoustical nerv

65.1

11.6

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

11.6

265

1685

A04

ICPC

Weakness/tiredness general

1.4

11.6

578

4298

N06AB06

ATC

sertraline; oral

1.4

11.5

446

3172

3542A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Lesion of ulnar nerve

+∞

11.5

A10AD01

ATC

insulin (human); parenteral

2.5

11.4

265

UKC02

NOMESCO Finland

Cystoscopy

1.4

11.4

611

4592

CBK10

NOMESCO Finland

Operation for lagophtalmus

120.3

11.4

H51.0

ICD-10 Finland

Palsy of conjugate gaze

120.3

11.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

11.4

260

1651

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

11.4

377

2600

M04AA01

ATC

allopurinol; systemic

1.4

11.4

496

3603

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.4

11.4

308

ZXD20

NOMESCO Finland

Day surgery

1.4

11.3

493

3580

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

11.3

1196

9888

G24.5

ICD-10 Finland

Blepharospasm

8.3

11.3

G56.4

ICD-10 Finland

Causalgia

35.1

11.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

11.3

1730

14921

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

4.0

11.2

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

11.2

100

476

J01FA09

ATC

clarithromycin; systemic

1.3

11.1

1290

10776

SPAT1254

SPAT

Administration of medicine

1.4

11.1

564

4202

E85.80

ICD-10 Finland

Meretoja sick

25.1

11.1

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

11.1

151

832

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

11.1

175

1009

A07AA02

ATC

nystatin; oral

1.7

11.0

217

1328

K08.80

ICD-10 Finland

Toothache NOS

1.5

11.0

334

2262

A10BJ05

ATC

dulaglutide; parenteral

2.3

11.0

363

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.5

10.9

265

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.3

10.9

357

Z2221

NOMESCO Finland

Medical doctor

1.3

10.9

1166

9642

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.9

1158

9570

B02.29

ICD-10 Finland

Herpes zoster polyneuropathy

43.4

10.9

R03BA05

ATC

fluticasone; inhalant

1.3

10.9

719

5579

H71

ICD-10 Finland

Cholesteatoma of middle ear

2.9

10.9

169

WX290

NOMESCO Finland

Other blockage of nerve

1.2

10.9

2001

17568

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

10.9

455

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.9

10.8

138

745

D07AC01

ATC

betamethasone; topical

1.2

10.8

1512

12894

K07.60

ICD-10 Finland

Snapping jaw

1.7

10.8

190

1129

M01AH01

ATC

celecoxib; oral

1.3

10.8

669

5143

A10BG02

ATC

rosiglitazone; oral

2.6

10.8

232

J01EA01

ATC

trimethoprim; systemic

1.3

10.8

1058

8662

G56.3

ICD-10 Finland

Lesion of radial nerve

8.8

10.7

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

10.7

217

1338

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

10.7

170

982

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.8

10.7

147

813

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

4.6

10.7

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.3

10.7

367

H93.1

ICD-10 Finland

Tinnitus

1.6

10.7

270

1757

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

10.7

128

678

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

10.6

102

499

M65.3

ICD-10 Finland

Trigger finger

1.8

10.6

144

793

C03DA01

ATC

spironolactone; oral

1.4

10.6

453

3277

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

10.6

1102

9082

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

10.5

421

3009

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.5

2983

27295

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

10.5

721

5627

SPAT1211

SPAT

Application of soft bandage

1.5

10.5

326

2220

A01

ICPC

Pain general/multiple sites

1.5

10.5

334

2286

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.9

10.5

162

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

14.2

10.5

P03

ICPC

Feeling depressed

1.5

10.5

358

2485

E0000UV, ,

ATC

1.2

10.4

1772

15412

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

10.4

488

3587

QAZ00

NOMESCO Finland

Botulin injections for hyperhidrosis of head and neck

110.2

10.4

35701

ICD-8 Finland

Other diseases of peripheral nerves except autonomic, Nervi mediani

+∞

10.4

G52.7

ICD-10 Finland

Disorders of multiple cranial nerves

+∞

10.4

L03AB07

ATC

interferon beta-1a; parenteral

3.5

10.4

101

R74

ICPC

Upper respiratory infection acute

1.3

10.4

1281

10763

C09CA06

ATC

candesartan; oral

1.3

10.4

951

7711

A10AB06

ATC

insulin glulisine; parenteral

2.9

10.4

168

H3600, E103,

ICD-10 Finland

3.0

10.4

152

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

10.4

369

2581

C09BA02

ATC

enalapril and diuretics; systemic

1.5

10.4

299

2004

R03BA02

ATC

budesonide; inhalant

1.3

10.4

700

5449

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

10.4

200

1219

D10

ICPC

Vomiting

1.6

10.4

220

1374

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

10.4

484

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

32.6

10.3

CBH10

NOMESCO Finland

Plactic repair of canthus

32.6

10.3

M79.1

ICD-10 Finland

Myalgia

1.4

10.3

548

4113

G56.9

ICD-10 Finland

Mononeuropathy of upper limb, unspecified

5.1

10.3

C03AA03

ATC

hydrochlorothiazide; oral

1.5

10.3

340

2344

N17

ICPC

Vertigo/dizziness

1.4

10.3

466

3408

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

4.4

10.2

M54.3

ICD-10 Finland

Sciatica

1.6

10.2

216

1347

N29

ICPC

Neurological sympt/complt other

2.2

10.2

355

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.3

10.2

336

OAB50, ,

SPAT

1.7

10.2

203

1247

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

10.2

184

1102

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.4

10.2

299

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.6

10.2

C01DA14

ATC

isosorbide mononitrate; oral

1.4

10.2

547

4113

M03BX01

ATC

baclofen; systemic

2.3

10.1

306

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.7

10.1

Z00.0

ICD-10 Finland

General medical examination

1.3

10.1

753

5942

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

10.1

206

1274

M79.7

ICD-10 Finland

Fibromyalgia

1.9

10.1

116

606

J01FA10

ATC

azithromycin; systemic

1.2

10.1

2515

22693

Z01.2

ICD-10 Finland

Dental examination

1.2

10.1

1920

16881

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

10.1

177

1053

G04CA02

ATC

tamsulosin; oral

1.3

10.0

865

6960

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

10.0

789

6275

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

10.0

304

2062

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

10.0

372

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

9.9

935

7606

K04.08

ICD-10 Finland

Other specified pulpit

1.5

9.9

285

1909

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

9.9

711

5580

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

9.9

445

G50.9

ICD-10 Finland

Disorder of trigeminal nerve, unspecified

16.7

9.9

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.8

498

3708

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

9.8

236

1519

A10AA01, ,

ATC

2.1

9.8

407

ZX120

NOMESCO Finland

Intravenous

1.4

9.8

368

2602

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

9.8

875

7072

L15

ICPC

Knee symptom/complaint

1.3

9.7

903

7330

TDA90

NOMESCO Finland

Removal wax from ear

2.5

9.7

238

M01AH03

ATC

valdecoxib; oral

1.6

9.7

220

1396

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.8

9.7

169

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

9.7

476

R03DC03

ATC

montelukast; oral

1.3

9.7

636

4929

L04AA06

ATC

mycophenolic acid; systemic

2.2

9.7

357

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.6

9.7

221

N06AX12

ATC

bupropion; oral

1.5

9.7

259

1709

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

9.6

330

2291

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.0

9.6

104

532

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

9.6

111

581

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

9.6

125

681

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

9.6

333

2319

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

3.2

9.6

117

N06

ICPC

Sensation disturbance other

2.9

9.6

154

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

9.6

253

1665

Z2446

NOMESCO Finland

Social worker

1.5

9.6

251

1649

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

9.6

1659

14433

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.0

9.6

138

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.2

9.5

340

H60.1

ICD-10 Finland

Cellulitis of external ear

2.6

9.5

211

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

9.5

285

1926

J01DA06

ATC

[U] cefuroxime

1.3

9.5

562

4288

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

9.5

132

734

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

9.5

438

3213

SPAT1097

SPAT

Recording of ECG

1.4

9.5

548

4168

J20

ICD-10 Finland

Acute bronchitis

1.4

9.5

387

2779

8500/3-C07.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of parotid gland

100.2

9.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

9.4

436

3200

3518X

ICD-9 Finland

Facial nerve disorders, Other facial nerve disorders

+∞

9.4

3519X

ICD-9 Finland

Facial nerve disorders, Facial nerve disorder, unspecified

+∞

9.4

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

2.8

9.4

156

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

9.4

384

2759

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

9.3

135

760

WX704

NOMESCO Finland

Intubation

1.5

9.3

287

1952

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.5

9.3

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

3.3

9.3

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.3

9.3

A10AA02, ,

ATC

1.9

9.3

107

560

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

8.7

9.3

A03

ICPC

Fever

1.3

9.3

645

5039

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

9.3

115

617

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

9.2

105

547

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.9

9.2

106

554

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

9.2

241

1582

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.2

902

7367

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

9.2

150

874

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

3.5

9.2

C02AC05

ATC

moxonidine; oral

1.7

9.2

166

995

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

9.1

414

3028

SPAT1255

SPAT

Intravenous administration of medicine

1.5

9.1

257

1716

ZZF00

NOMESCO Finland

Graft of adipose tissue

2.9

9.1

142

N30.0

ICD-10 Finland

Acute cystitis

1.3

9.1

629

4909

A10AD04

ATC

insulin lispro; parenteral

4.6

9.0

SGA01

NOMESCO Finland

Emergency treatment

1.3

9.0

631

4932

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.0

932

7662

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

9.0

178

1094

R21

ICPC

Throat symptom/complaint

1.3

9.0

795

6412

KMAK, ,

NOMESCO Finland

1.2

9.0

2234

20076

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

9.0

1331

11385

B01AB05

ATC

enoxaparin; parenteral

1.2

8.9

1263

10745

N05CF02

ATC

zolpidem; oral

1.3

8.9

685

5421

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

8.9

224

1457

XKC03

NOMESCO Finland

Water cystometry

1.9

8.9

111

596

C08CA02

ATC

felodipine; oral

1.4

8.9

346

2461

SPAT1050

SPAT

Extensive neurological examination

2.1

8.9

396

H19.8*E85.80

ICD-10 Finland

Reticular keratitis in Meretoja's patients

24.0

8.9

R01AD08

ATC

fluticasone; nasal

1.2

8.9

1177

9944

A10AD05

ATC

insulin aspart; parenteral

2.3

8.9

286

N06AX26

ATC

vortioxetine; oral

1.5

8.9

267

1807

N93

ICPC

Carpal tunnel syndrome

3.7

8.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.8

363

2609

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.8

985

8166

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

8.8

236

1559

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.6

8.8

196

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

8.8

313

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.8

8.8

145

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

8.8

256

1722

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

8.7

1361

11694

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

8.7

412

3034

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

8.7

491

3720

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

8.7

104

552

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.7

439

3269

N05AH04

ATC

quetiapine; oral

1.3

8.6

677

5375

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.6

492

3734

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

3.2

8.6

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

8.6

319

2251

164

Kela drug reimbursment

Fingolimod

4.8

8.6

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

2.9

8.6

136

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.1

8.6

369

SPAT1312

SPAT

General health counselling

1.2

8.5

1280

10952

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

9.0

8.5

CBF20

NOMESCO Finland

Resection of part of tarsus for ectropion

10.0

8.5

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

8.5

481

3645

R33

ICD-10 Finland

Retention of urine

1.5

8.5

281

1940

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

27.5

8.5

M01AX17

ATC

nimesulide; oral

1.3

8.5

898

7398

H36.01

ICD-10 Finland

Diabetic maculopathy

2.5

8.4

206

S21

ICPC

Skin texture symptom/complaint

1.3

8.4

536

4132

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

8.4

192

1222

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

8.4

917

7577

H62.1*B00.19

ICD-10 Finland

Otitis externa in herpesviral [herpes simplex] infection

90.2

8.4

J01MA14

ATC

moxifloxacin; systemic

1.4

8.4

337

2412

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

8.4

1185

10072

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

8.4

117

652

S06.0

ICD-10 Finland

Concussion

1.4

8.4

397

2924

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

8.4

904

7463

C10AX09

ATC

ezetimibe; oral

1.3

8.3

576

4493

4182

FHL

Surgery on the facial nerve

+∞

8.3

R55

ICD-10 Finland

Syncope and collapse

1.4

8.3

405

2997

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

8.3

142

840

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

8.3

336

2409

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

8.3

483

3676

OAB42, ,

SPAT

1.4

8.3

375

2742

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.9

8.3

128

M01AH02

ATC

rofecoxib; oral

1.4

8.3

446

3356

L04AX01

ATC

azathioprine; systemic

1.7

8.2

160

979

N03AX11

ATC

topiramate; oral

2.0

8.2

436

H65.0

ICD-10 Finland

Acute serous otitis media

2.2

8.2

309

S22.3

ICD-10 Finland

Fracture of rib

1.5

8.2

259

1771

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

8.2

513

L04AX03

ATC

methotrexate; systemic

1.4

8.2

358

2602

SPAT1360

SPAT

Extensive global examination

1.5

8.2

252

1715

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.9

8.1

129

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

8.1

107

586

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

3.6

8.1

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

8.1

232

1555

SPAT1229

SPAT

Assessment of need for aid

1.5

8.1

265

1826

G51.4

ICD-10 Finland

Facial myokymia

6.8

8.0

N05BA04

ATC

oxazepam; oral

1.2

8.0

1040

8757

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

8.0

492

3775

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

7.9

262

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.9

435

3281

A02BA04

ATC

nizatidine; systemic

1.5

7.9

270

1875

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.6

7.9

165

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

7.9

485

3720

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.8

7.9

137

R4110, ,

SPAT

1.4

7.9

308

2195

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

7.7

7.9

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

7.8

437

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

7.8

342

2486

N05CD07

ATC

temazepam; oral

1.4

7.8

420

3158

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

3.1

7.8

100

C07AG02

ATC

carvedilol; oral

1.5

7.8

211

1398

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

7.8

301

2141

A01AB09

ATC

miconazole; local oral

1.4

7.8

308

2201

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

7.8

794

6511

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

7.7

382

2833

E66

ICD-10 Finland

Obesity

1.6

7.7

186

1200

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

7.7

453

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.7

317

2279

N99

ICPC

Neurological disease other

2.4

7.7

209

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

2.5

7.7

185

R03AC03

ATC

terbutaline; inhalant

1.3

7.7

527

4106

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

7.7

330

2393

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.2

7.6

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

7.6

1513

13270

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.5

7.6

180

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.5

7.6

180

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.5

7.6

186

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.2

7.6

286

N06AB10

ATC

escitalopram; oral

1.3

7.6

792

6505

K30

ICD-10 Finland

Functional dyspepsia

1.4

7.6

412

3101

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

7.6

411

3093

S01BC03

ATC

diclofenac; ophthalmic

1.9

7.6

491

XKD00

NOMESCO Finland

Uroflowmetry

1.3

7.6

564

4444

EB1VA, ,

NOMESCO Finland

1.3

7.6

459

3514

R06AX22

ATC

ebastine; oral

1.3

7.6

657

5281

GBB00

NOMESCO Finland

Tracheostomy

2.5

7.6

187

K11.2

ICD-10 Finland

Sialoadenitis

1.7

7.5

120

697

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

3.8

7.5

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.6

7.5

158

F03

ICPC

Eye discharge

1.5

7.5

241

1655

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

7.5

245

1688

C10AB05

ATC

fenofibrate; oral

2.1

7.5

321

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

7.5

248

1713

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

7.5

235

1606

Z50.1

ICD-10 Finland

Other physical therapy

1.6

7.5

181

1170

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

7.5

127

751

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.5

1793

15986

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

7.5

147

904

SFA20

NOMESCO Finland

Two-surface restoration

1.2

7.4

2543

23340

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

7.4

554

4367

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

7.4

372

2768

R01AD11

ATC

triamcinolone; nasal

1.4

7.4

321

2331

E000001, ,

ATC

1.3

7.4

771

6335

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

7.4

700

5688

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

7.3

101

562

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

2.0

7.3

406

DFF59

NOMESCO Finland

Other assessment of balance

2.5

7.3

184

H10

ICD-10 Finland

Conjunctivitis

1.4

7.3

270

1906

AAH60

NOMESCO Finland

Microvascular decompression of cranial nerve

+∞

7.3

EAB20

NOMESCO Finland

Plastic repair of lip

10.9

7.3

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

7.3

228

1559

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

7.3

168

1075

H15.0

ICD-10 Finland

Scleritis

4.1

7.3

P76

ICPC

Depressive disorder

1.5

7.3

227

1551

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

7.3

112

645

H60

ICD-10 Finland

Otitis externa

1.5

7.2

194

1283

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

7.2

740

6066

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

7.2

1002

8488

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.8

7.2

102

573

K04.0

ICD-10 Finland

Pulpitis

1.4

7.2

346

2557

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

7.2

553

4377

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

7.2

168

1078

H01.0

ICD-10 Finland

Blepharitis

1.5

7.2

235

1621

A98

ICPC

Health maint/preventive medicine

1.3

7.1

4888

47680

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

7.1

211

1426

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

20.0

7.1

A12BA01

ATC

potassium chloride; oral

1.6

7.1

146

908

N06AB03

ATC

fluoxetine; oral

1.3

7.1

453

3495

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

3.3

7.1

CBN99

NOMESCO Finland

Other operation on eyelid for malposition

3.3

7.1

H70.0

ICD-10 Finland

Acute mastoiditis

7.9

7.1

P06

ICPC

Sleep disturbance

1.3

7.1

425

3250

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

7.1

687

5596

H29

ICPC

Ear symptom/complaint other

1.3

7.1

419

3198

G04BD08

ATC

solifenacin; oral

1.5

7.1

232

1601

C07AA05

ATC

propranolol; systemic

1.2

7.1

788

6521

R03BA08

ATC

ciclesonide; inhalant

1.4

7.0

308

2240

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

7.0

454

3508

N05BA01

ATC

diazepam; systemic, rectal

1.3

7.0

481

3747

S02.10

ICD-10 Finland

Fracture of base of skull, closed

3.6

7.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

7.0

162

1037

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.1

7.0

297

D01AC02

ATC

miconazole; topical

1.4

7.0

271

1931

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.0

670

5451

SAA04

NOMESCO Finland

Special examination of mouth

1.5

7.0

182

1198

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.1

7.0

304

D02

ICPC

Abdominal pain epigastric

1.5

7.0

213

1450

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

6.9

293

2118

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.9

217

1483

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

6.9

182

1200

WX720

NOMESCO Finland

Own respiration

1.6

6.9

158

1009

C07AB02

ATC

metoprolol; systemic

1.2

6.9

735

6051

N06AA10

ATC

nortriptyline; systemic

2.0

6.9

332

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

7.5

6.9

G63.0*B02.29

ICD-10 Finland

Postherpetic polyneuropathy

13.8

6.9

R75

ICPC

Sinusitis acute/chronic

1.6

6.8

162

1043

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

6.8

475

3708

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.1

6.8

306

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

6.8

414

3171

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.4

6.8

178

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

6.8

174

1140

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

6.8

157

1005

SPAT1283

SPAT

Restricted health certificate

1.3

6.8

625

5059

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.8

484

3793

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.8

157

1006

S97

ICPC

Chronic ulcer skin

1.5

6.8

195

1311

C07

ICD-10 Finland

Malignant neoplasm of parotid gland

40.1

6.8

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

6.7

776

6442

162

Kela drug reimbursment

liraglutide

2.5

6.7

155

3AX01, ,

NOMESCO Finland

5.6

6.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

6.7

182

1207

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

6.7

397

3029

D06

ICPC

Abdominal pain localized other

1.4

6.7

309

2268

R01AD58

ATC

fluticasone, combinations; nasal

1.2

6.7

944

8004

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.6

6.7

138

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.0

6.7

329

N03AF02

ATC

oxcarbazepine; oral

1.7

6.7

108

631

R4130

NOMESCO Finland

Speech therapy

1.8

6.7

535

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

22.5

6.7

J45.8

ICD-10 Finland

Mixed asthma

1.7

6.6

108

632

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.9

6.6

456

N02AC04

ATC

dextropropoxyphene; oral

1.7

6.6

115

685

D07AA02

ATC

hydrocortisone; topical

1.3

6.6

511

4045

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

6.6

337

ZX114

NOMESCO Finland

Intramuscular

2.2

6.6

231

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

6.6

435

3371

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

6.6

269

1934

L04AA27

ATC

[U] fingolimod

5.9

6.6

H02.5

ICD-10 Finland

Other disorders affecting eyelid function

5.9

6.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

6.6

508

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.6

209

1434

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.5

6.6

167

1093

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.2

6.6

238

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.0

6.6

311

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.0

6.6

311

H3601, E103,

ICD-10 Finland

2.8

6.6

111

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

6.6

326

2423

B02.20

ICD-10 Finland

Herpes zoster trigeminal neuralgia

8.7

6.5

G53.0*B02.20

ICD-10 Finland

Trigeminal neuralgia after shingles

10.0

6.5

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.4

6.5

176

K08.3

ICD-10 Finland

Retained dental root

1.4

6.5

271

1958

A28

ICPC

Limited function/disability NOS

1.3

6.5

601

4871

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

6.4

216

1498

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

6.4

194

1317

N06AX22

ATC

agomelatine; oral

1.9

6.4

432

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.4

249

1774

ELB40

NOMESCO Finland

Partial parotidectomy

2.2

6.4

221

S02.11

ICD-10 Finland

Fracture of base of skull, open

3.9

6.4

X58

ICD-10 Finland

Exposure to other specified factors

1.3

6.4

511

4062

A10BH02

ATC

vildagliptin; oral

1.9

6.4

369

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

6.4

267

1927

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.4

6.4

229

1608

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

6.4

240

1700

R06AX27

ATC

desloratadine; oral

1.2

6.4

1120

9695

M54

ICD-10 Finland

Dorsalgia

1.3

6.4

453

3550

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

6.3

347

2618

B02AA02

ATC

tranexamic acid; systemic

1.3

6.3

534

4275

L03.2

ICD-10 Finland

Cellulitis of face

2.7

6.3

119

A99

ICPC

Disease/condition unspecnature/site

1.4

6.3

327

2446

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

6.3

145

928

A11

ICPC

Chest pain NOS

1.4

6.3

287

2103

L02

ICPC

Back symptom/complaint

1.3

6.3

352

2664

J02AC02

ATC

itraconazole; systemic

1.2

6.3

673

5540

R20.1

ICD-10 Finland

Hypoaesthesia of skin

2.9

6.3

R4190

NOMESCO Finland

Nutritional therapy

1.6

6.3

129

804

C10AB02

ATC

bezafibrate; oral

2.3

6.3

198

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

6.3

799

6704

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

6.3

127

789

Q51.0

ICD-10 Finland

Agenesis and aplasia of uterus

18.0

6.3

G52.8

ICD-10 Finland

Disorders of other specified cranial nerves

+∞

6.2

CBH05

NOMESCO Finland

Canthopexy

+∞

6.2

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

6.2

181

1220

A29

ICPC

General symptom/complaint other

1.3

6.2

453

3559

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.3

6.2

186

C07.71

ICD-10 Finland

Malignant tumor in the deep part of the parotid gland

26.7

6.2

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

6.2

163

1075

A10BX02

ATC

repaglinide; oral

2.3

6.2

205

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.4

6.2

233

1651

H02AB09

ATC

hydrocortisone; systemic

1.8

6.2

474

SPAT1053

SPAT

Memory test

1.3

6.2

488

3875

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

1.9

6.2

367

R06.2

ICD-10 Finland

Wheezing

1.6

6.2

151

981

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

6.2

243

1738

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

2.9

6.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

6.1

802

6745

N07AA02

ATC

pyridostigmine; systemic

3.2

6.1

UDM02

NOMESCO Finland

Sinoscopy

1.8

6.1

425

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

6.1

220

1547

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.1

252

1816

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

6.1

171

1144

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

6.1

991

8511

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

7.7

6.1

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

7.7

6.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

6.1

289

2132

J01MA04

ATC

enoxacin; oral

2.3

6.1

194

C09DA01

ATC

losartan and diuretics; oral

1.3

6.1

384

2958

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.0

6.1

320

ZZR30

NOMESCO Finland

Flap of muscle

3.8

6.1

S22

ICPC

Nail symptom/complaint

1.4

6.1

213

1492

R04.2

ICD-10 Finland

Haemoptysis

1.7

6.1

115

703

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

6.1

142

914

S10

ICPC

Boil/carbuncle

1.5

6.0

201

1393

JAH01

NOMESCO Finland

Laparoscopy

1.6

6.0

149

970

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.0

652

5374

A10BD15

ATC

metformin and dapagliflozin; oral

2.6

6.0

128

C10AA04

ATC

fluvastatin; oral

1.4

6.0

290

2146

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

6.0

385

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1309

2665

6.20

307.65

2.5

2.3

21.64

22.74

au/ml

0.12

225

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1221

2425

6.25

307.65

1.4

1.3

61.42

47.89

au/ml

0.94

139

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

235

344

7.10

153.12

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

358

846

4.47

138.61

1.4

1.2

3.82

3.75

mmol/l

0.48

339

795

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

382

968

4.18

134.93

1.5

1.3

570.82

513.45

mg/l

1.10

368

912

(3044290) Cell count panel - Cerebral spinal fluid

331

784

4.44

127.63

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

134

137

10.01

116.91

1.1

980.39

251.65

ng/l

0.84

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

334

853

4.11

116.47

1.5

1.4

471.91

1316.70

e6/l

1.10

266

684

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

333

852

4.10

115.82

1.5

1.4

39.69

16.36

e6/l

0.89

253

639

(3013826) Glucose [Moles/volume] in Serum or Plasma

3193

24246

1.80

89.97

5.2

4.6

7.00

6.65

mmol/l

12.22

3011

22603

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1867

12121

1.84

89.00

2.2

2.1

215.94

220.92

u/l

0.07

1775

11358

(3016018) Differential panel - Cerebral spinal fluid

198

414

4.93

88.73

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

136

208

6.69

84.86

1.1

1.11

u/l

0.05

101

(3023410) Appearance of Cerebral spinal fluid

178

394

4.64

74.43

1.7

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1099

6340

1.93

73.59

2.2

2.1

29.37

29.88

2.30

1075

6142

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

201

6.29

73.13

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2554

18855

1.69

73.09

12.8

14.8

1.19

1.26

inr

4.53

790

5554

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

147

282

5.33

72.66

1.1

348.88

264.57

mg/l

1.33

125

246

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

149

292

5.22

71.91

1.2

1.1

49.61

40.70

mg/l

0.81

126

240

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

209

6.05

70.32

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

7.19

65.13

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

132

270

4.99

60.66

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

115

221

5.30

56.74

1.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2069

15247

1.59

54.15

3.9

3.4

36.56

48.43

ng/l

1.43

1422

10167

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

132

300

4.49

53.41

1.2

1.3

2.05

2.02

mmol/l

0.11

127

277

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2594

20308

1.55

50.89

7.5

6.6

1.21

mmol/l

0.32

2206

17213

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

143

362

4.03

50.25

1.3

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1712

12254

1.59

49.66

4.2

3.7

9.63

9.45

mg/mmol

0.05

1142

7764

(3012516) Albumin [Mass/volume] in Urine

1638

11645

1.59

48.70

3.5

3.2

503.73

309.92

mg/l

0.81

1112

7420

(3009508) Creatinine [Moles/volume] in Urine

1742

12582

1.57

48.28

3.4

3.1

7.65

mmol/l

0.02

1459

10636

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2682

21358

1.52

47.20

6.4

6.3

11.00

11.55

umol/l

1.61

2572

20257

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4704

42811

1.92

46.38

17.4

13.4

21.66

24.02

mg/l

5.49

3974

33555

(3013707) Erythrocyte sedimentation rate by Westergren method

3627

30988

1.55

44.58

4.6

3.8

12.38

11.95

mm/h

1.05

3414

28640

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

195

5.00

44.51

1.3

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2355

18404

1.51

44.30

6.7

5.9

1.21

mmol/l

0.15

2166

16757

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

150

5.61

43.82

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4790

44038

1.96

43.10

19.9

15.4

3.96

mmol/l

1.06

4693

42786

(3019550) Sodium [Moles/volume] in Serum or Plasma

4778

43894

1.94

43.05

19.7

15.2

139.61

139.67

mmol/l

0.92

4688

42727

(3024561) Albumin [Mass/volume] in Serum or Plasma

2265

17652

1.50

42.63

5.1

4.9

35.62

35.52

g/l

0.39

2095

16397

(40760892) CBC W Ordered Manual Differential panel - Blood

2474

19652

1.49

42.23

7.5

6.4

—

(3023368) Bacteria identified in Blood by Culture

1522

10972

1.54

41.10

4.6

4.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3717

32269

1.51

39.33

8.4

7.4

78.14

u/l

0.00

3508

30368

(3006315) Basophils [#/volume] in Blood

2583

20930

1.46

38.43

6.9

5.8

0.04

e9/l

0.18

2234

18011

(3001604) Monocytes [#/volume] in Blood

2576

20880

1.46

38.15

6.9

5.8

0.60

0.59

e9/l

1.19

2232

17976

(3019198) Lymphocytes [#/volume] in Blood

2638

21501

1.45

37.81

7.0

5.9

1.90

1.91

e9/l

0.10

2335

18961

(3022096) Basophils/100 leukocytes in Blood

2374

19023

1.45

36.91

7.2

6.1

0.66

0.68

1.04

2232

17729

(3013115) Eosinophils [#/volume] in Blood

2643

21647

1.44

36.32

7.1

6.1

0.20

0.19

e9/l

0.39

2321

18909

(3019069) Monocytes/100 leukocytes in Blood

2446

19751

1.44

36.27

7.5

6.3

8.57

8.58

0.09

2308

18480

(3013650) Neutrophils [#/volume] in Blood by Automated count

2912

24293

1.44

36.16

9.9

9.2

4.24

4.10

e9/l

2.27

2560

21098

(3037467) Urinalysis macro (dipstick) panel - Urine

3377

28984

1.46

35.90

4.9

4.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

750

4691

1.70

35.82

1.8

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

2504

20341

1.44

35.75

7.2

6.1

27.33

27.87

1.62

2376

19065

(3006504) Eosinophils/100 leukocytes in Blood

2430

19635

1.44

35.69

7.2

6.0

2.79

2.85

0.71

2291

18332

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

5.88

35.64

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

536

3079

1.82

34.36

2.8

2.7

9.96

10.56

g/l

2.79

491

2802

(3018010) Neutrophils/100 leukocytes in Blood

2460

20043

1.43

33.86

6.9

5.9

57.94

57.26

2.16

2326

18775

(3031040) Bacteria [#/volume] in Urine by Automated count

3218

27590

1.43

32.79

5.2

4.2

585.24

1702.97

e6/l

1.30

358

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

337

1701

2.05

31.73

2.6

1.9

39.95

39.39

u/l

0.19

312

1507

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1663

12728

1.45

31.65

2.8

2.5

55.22

60.76

u/l

3.80

1533

11735

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.12

31.39

1.1

—

(3018418) pH of Serum or Plasma

1583

12108

1.44

29.84

4.4

4.0

7.40

0.07

331

2337

(3026008) Bacteria identified in Urine by Culture

1618

12465

1.43

29.18

3.4

3.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4262

38837

1.51

29.15

6.9

5.3

41.70

39.26

mmol/mol

32.46

3962

35940

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.93

28.18

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4288

39199

1.50

28.12

5.2

4.6

1.87

2.14

mu/l

2.12

3970

35936

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2052

16563

1.39

27.97

2.1

1.9

95.51

95.49

pmol/l

0.01

1081

8604

(3000850) Epithelial cells [#/volume] in Urine

1184

8680

1.47

27.54

2.8

2.6

5.39

5.71

e6/l

0.42

1062

7753

(3036481) Cortisol [Moles/volume] in Serum or Plasma

582

3669

1.66

26.51

2.4

2.2

349.22

378.18

nmol/l

3.06

537

3368

(3002582) Erythrocytes [#/volume] in Urine

1611

12624

1.40

25.62

3.6

3.2

154.46

93.92

e6/l

0.36

1243

9599

(3033658) Prothrombin time (PT) actual/Normal

1414

10864

1.41

25.12

4.3

3.9

92.40

90.13

2.91

1389

10602

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4396

40642

1.49

24.80

15.8

12.5

82.14

81.98

ml/min/173m2

0.17

3716

33495

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3640

32582

1.38

24.33

4.4

3.9

14.74

14.75

pmol/l

0.15

3339

29638

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

914

6517

1.49

24.08

1.9

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1490

11624

1.39

24.00

3.4

3.1

0.41

0.43

e6/l

0.14

1134

8753

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1070

7877

1.45

23.89

3.9

3.6

518.43

542.90

ng/l

0.04

784

6064

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

188

3.81

23.58

1.3

57.79

68.50

0.47

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2190

18205

1.35

23.46

3.1

2.8

115.45

128.30

ug/l

2.06

1995

16866

(40761511) CBC panel - Blood by Automated count

4760

44901

1.62

23.19

16.5

12.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4842

45877

1.68

23.09

12.2

9.9

28.47

26.47

u/l

2.72

4683

44176

(3026782) Osmolality of Urine

1113

8307

1.43

22.95

3.1

2.8

530.93

543.40

mosm/kgh2o

1.08

956

7117

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1333

10282

1.40

22.74

2.4

2.2

3.06

2.93

mg/l

1.10

1132

8765

(3018095) Leukocytes [#/volume] in Urine

1824

14798

1.36

22.73

4.2

3.6

117.09

97.45

e6/l

0.27

1313

10328

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2329

19634

1.33

22.30

2.8

2.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1385

10816

1.38

21.76

2.9

2.6

3038.82

4685.23

umol/l

0.91

1225

9516

(3009261) Glucose [Presence] in Urine by Test strip

2440

20761

1.33

21.69

4.2

3.5

0.01

0.00

estimate

0.18

475

3800

(3021589) Normoblasts [#/volume] in Blood

2254

18967

1.33

21.63

10.9

9.3

0.00

e9/l

0.12

1874

15451

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1697

13700

1.35

21.55

3.6

3.2

32.17

36.26

u/l

1.71

1600

12993

(3042936) Bacteria identified in Isolate by Culture

803

5695

1.48

21.51

2.0

1.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

247

3.27

21.10

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

2408

20534

1.32

20.71

5.6

4.7

0.00

estimate

0.34

487

3899

(3003458) Phosphate [Moles/volume] in Serum or Plasma

744

5240

1.49

20.57

6.5

5.8

1.05

1.04

mmol/l

0.70

686

4887

(36304419) Bacteria [Presence] in Urine

1429

11306

1.36

20.46

3.4

3.0

—

(3035350) Ketones [Presence] in Urine by Test strip

2406

20541

1.32

20.41

4.2

3.5

0.00

estimate

1.90

523

4105

(3037522) Nuclear Ab [Titer] in Serum

764

5420

1.48

20.35

1.4

1.3

471.00

546.89

titre

0.63

160

1126

(3009542) Hematocrit [Volume Fraction] of Blood

5006

48078

1.82

19.95

25.6

19.8

41.26

40.43

0.39

4737

45241

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

649

4474

1.51

19.86

1.9

1.8

—

(3007461) Platelets [#/volume] in Blood

5007

48117

1.81

19.54

25.5

19.7

252.32

251.34

e9/l

0.50

4896

46847

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1411

11207

1.35

19.53

3.2

3.0

1399.43

1431.71

ng/l

0.10

1182

9577

(3019309) Folate [Moles/volume] in Red Blood Cells

981

7344

1.41

19.51

1.8

1.7

1153.38

1169.08

nmol/l

0.21

760

5528

(3035941) MCH [Entitic mass]

5008

48143

1.80

19.32

25.4

19.6

30.14

30.30

8.37

4957

47438

(3024731) MCV [Entitic volume]

5008

48143

1.80

19.32

25.4

19.6

90.56

90.95

7.82

4956

47440

(3010813) Leukocytes [#/volume] in Blood

5008

48147

1.80

19.26

25.5

19.7

6.97

6.71

e9/l

8.64

4892

46732

(3026361) Erythrocytes [#/volume] in Blood

5008

48151

1.80

19.20

25.5

19.6

4.51

4.50

e12/l

0.92

4894

46748

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3206

28596

1.31

19.15

3.5

3.0

49.34

47.56

u/l

0.64

3009

26659

(3000963) Hemoglobin [Mass/volume] in Blood

5008

48161

1.80

19.04

25.7

19.8

135.31

135.63

g/l

0.80

4959

47458

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

643

4471

1.50

18.83

1.8

1.7

—

(3015736) pH of Urine

1978

16566

1.31

18.78

3.8

3.2

5.80

5.86

0.34

143

1316

(3021960) Folate [Moles/volume] in Serum or Plasma

1183

9213

1.37

18.41

1.6

1.5

19.82

20.46

nmol/l

0.74

1005

7882

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1108

8565

1.37

18.02

1.8

1.6

74589723.82

32278019.79

pmol/l

0.62

913

7104

(3044640) Blood type and Crossmatch panel - Blood

1633

13379

1.32

17.98

2.6

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4400

41254

1.40

17.84

5.0

4.3

6.13

5.88

mmol/l

20.05

4031

37630

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

205

1067

1.96

17.72

2.5

2.0

10.34

11.48

mg/l

0.88

190

984

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.33

17.53

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

234

3.11

17.51

1.1

4.45

11.86

nmol/l

0.55

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1164

9116

1.36

17.33

2.0

1.7

1.30

1.21

mg/l

0.18

887

6902

(3022948) Iron [Moles/volume] in Serum or Plasma

850

6338

1.41

17.07

2.7

2.4

12.79

13.20

umol/l

0.89

786

5924

(3004789) Transferrin [Mass/volume] in Serum or Plasma

792

5847

1.42

16.82

2.7

2.4

2.38

2.33

g/l

1.86

729

5424

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

747

5467

1.43

16.65

2.7

2.5

22.07

23.04

1.10

620

4710

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2015

17124

1.29

16.48

2.4

2.2

75.18

77.22

nmol/l

2.67

1830

15434

(3012095) Magnesium [Moles/volume] in Serum or Plasma

876

6634

1.38

15.96

3.4

0.82

mmol/l

0.56

828

6230

(3002385) Erythrocyte distribution width [Ratio]

4008

37213

1.32

15.94

20.1

16.1

14.99

14.95

0.10

3952

36504

(3028679) Herpes simplex virus Ab [Presence] in Serum

201

3.16

15.84

1.1

—

(3013512) EKG study

1447

11826

1.31

15.79

4.3

3.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

108

4.01

15.46

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

125

570

2.22

15.40

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

969

7498

1.36

15.37

1.6

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

5.50

15.22

1.2

78.40

59.33

1.29

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

883

6743

1.37

15.22

1.3

37.23

32.04

iu/ml

0.33

309

2130

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

3.88

15.17

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

499

3446

1.49

14.99

4.1

4.2

0.93

0.96

0.12

167

1170

(3003396) Base excess in Arterial blood by calculation

624

4502

1.44

14.96

7.6

0.93

1.06

mmol/l

0.33

476

3548

(3021447) Carbon dioxide [Partial pressure] in Venous blood

531

3715

1.48

14.95

4.4

3.7

5.82

5.81

kpa

0.11

513

3602

(3002032) Base excess in Venous blood by calculation

530

3709

1.48

14.90

4.4

3.8

1.69

1.88

mmol/l

0.61

454

3142

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

107

3.95

14.82

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1861

15811

1.27

14.80

4.4

3.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1663

13935

1.28

14.78

3.3

3.5

2.35

mmol/l

0.14

1452

12262

(3027801) Oxygen [Partial pressure] in Arterial blood

624

4522

1.43

14.58

7.6

12.08

12.50

kpa

1.37

597

4304

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

624

4522

1.43

14.58

7.6

5.06

5.08

kpa

0.21

597

4299

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

3.79

14.37

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

275

1672

1.68

14.27

1.5

31.50

15.06

u/ml

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

429

2902

1.52

14.22

1.8

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

474

3275

1.49

14.19

4.1

4.3

0.08

0.12

0.58

145

1000

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

916

7115

1.35

14.05

3.0

2.7

1.02

1.17

e6/l

0.59

514

3991

(3002179) Metamyelocytes/100 leukocytes in Blood

457

3157

1.49

13.68

3.7

4.1

0.66

0.72

0.26

144

1010

(3025159) Blasts/100 leukocytes in Blood

451

3110

1.49

13.62

4.1

4.3

0.06

0.32

1.13

120

841

(3020630) Protein [Mass/volume] in Serum or Plasma

468

3255

1.48

13.55

2.6

66.33

66.47

g/l

0.16

428

2973

(3044889) 12 lead EKG panel

3240

29549

1.25

13.32

4.0

3.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

6.31

13.27

1.1

5.89

18.45

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1247

10210

1.29

12.98

2.4

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

440

3057

1.48

12.79

3.9

3.1

4.63

kpa

0.03

422

2952

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

105

3.73

12.78

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.00

12.61

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

817

6344

1.34

12.43

1.3

1.2

10.01

12.34

u/ml

0.44

302

2514

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4520

43077

1.35

12.38

5.2

4.6

2.72

2.79

mmol/l

5.49

4183

39781

(3016502) Oxygen saturation in Arterial blood

550

4012

1.41

12.32

8.1

95.66

95.68

0.02

532

3853

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

123

3.43

12.18

1.1

1.2

18.10

23.08

—

(3019150) Specific gravity of Urine by Refractometry

1074

8689

1.30

12.15

4.6

3.8

1.02

kg/l

0.35

156

1287

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

479

3417

1.44

12.14

2.3

7.63

7.87

ug/l

0.06

410

2993

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

531

3863

1.42

12.07

2.3

0.22

0.21

g/l

1.44

495

3594

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

851

6675

1.33

12.06

3.3

2.9

3.50

2.58

e6/l

1.20

447

3579

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

449

2.18

11.62

1.5

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

509

3703

1.41

11.56

8.4

8.5

120.92

121.62

g/l

0.33

499

3597

(3004588) Protein electrophoresis panel - Serum or Plasma

385

2659

1.48

11.53

2.4

2.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

318

2.41

11.52

2.4

2.1

71.80

72.54

0.13

306

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4443

42328

1.32

11.50

4.8

4.2

4.58

4.69

mmol/l

9.75

4137

39301

(40768804) Tissue Pathology biopsy report

2001

17501

1.23

11.46

2.2

2.1

—

(3011412) CD3 cells [#/volume] in Blood

394

2.25

11.44

2.6

2.5

1.25

1.17

e9/l

0.35

357

(3017143) Hepatitis C virus Ab [Presence] in Serum

641

4858

1.36

11.38

1.8

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1338

11206

1.26

11.33

3.8

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1308

10937

1.26

11.22

4.7

3.9

0.00

estimate

1.98

473

3734

(3028026) IgM [Mass/volume] in Serum or Plasma

352

2403

1.50

11.17

2.2

1.9

1.59

1.35

g/l

0.61

328

2186

(3014148) Varicella zoster virus Ab [Titer] in Serum

108

530

2.06

11.15

1.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

640

4871

1.36

11.05

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

283

1852

1.56

10.93

3.5

3.3

25.37

25.24

mmol/l

0.26

273

1792

(40768797) Stomach Pathology biopsy report

717

5573

1.33

10.74

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

195

1175

1.68

10.54

1.6

0.25

0.24

g/l

1.73

180

1108

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

301

2.38

10.49

2.3

2.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

356

2471

1.47

10.41

4.2

3.6

5.14

5.16

kpa

0.19

331

2340

(3027945) Reticulocytes/100 erythrocytes in Blood

587

4452

1.36

10.34

2.7

2.6

1.90

1.78

1.53

505

3933

(46235355) HIV 1 and 2 tests - Meaningful Use set

953

7742

1.28

10.26

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

164

2.88

10.25

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

215

1339

1.63

10.24

1.7

1.6

168.89

367.69

titre

—

(3009343) pH of Capillary blood

351

2444

1.47

10.10

4.2

3.6

7.42

7.41

0.73

291

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

341

2363

1.47

10.06

4.2

3.5

1.71

1.79

mmol/l

0.16

249

1751

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

195

1192

1.66

10.00

1.5

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4400

42029

1.28

9.98

4.7

4.2

1.39

1.47

mmol/l

29.73

4070

38816

(3008152) Bicarbonate [Moles/volume] in Arterial blood

347

2417

1.47

9.97

9.0

7.1

24.42

24.50

mmol/l

0.16

330

2293

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

198

1221

1.65

9.82

1.6

1.24

1.19

g/l

1.67

187

1151

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4263

40587

1.26

9.78

4.3

3.8

1.41

1.29

mmol/l

19.23

3914

37189

(3020779) Urea [Moles/volume] in Serum or Plasma

496

3697

1.38

9.74

8.3

7.4

9.92

9.62

mmol/l

0.37

466

3526

(3004119) Hemoglobin [Mass/volume] in Venous blood

345

2418

1.46

9.61

3.7

3.2

127.91

129.11

g/l

0.43

334

2357

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

407

2941

1.42

9.60

4.2

3.8

94.69

89.99

ng/l

0.40

342

2522

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

602

4639

1.34

9.53

4.5

4.4

257.03

243.41

u/l

0.79

562

4393

(40758558) Short blood count panel - Blood

1273

10783

1.24

9.48

7.4

7.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

124

679

1.85

9.37

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

124

679

1.85

9.37

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

150

873

1.74

9.25

2.3

2.1

130.37

128.84

g/l

0.28

116

621

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

561

4298

1.34

9.23

3.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

456

3388

1.38

9.13

3.6

3.9

1.23

mmol/l

0.05

409

2958

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1090

9114

1.25

9.08

1.3

1.2

1.85

1.92

u/ml

0.05

282

2426

(3009214) Lutropin [Units/volume] in Serum or Plasma

186

1154

1.63

9.04

1.3

1.4

11.32

10.05

u/l

0.59

144

954

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

241

1592

1.54

8.97

6.4

5.4

1.71

1.65

0.32

229

1483

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.20

8.90

1.1

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

167

1013

1.67

8.86

1.7

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

128

2.98

8.86

1.3

2.1

575.00

27821.29

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

418

2.05

8.81

1.5

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

201

1280

1.59

8.79

2.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

921

7582

1.26

8.77

2.8

3.1

2.45

mmol/l

0.11

783

6645

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.12

8.70

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

237

1574

1.53

8.62

6.4

5.5

0.88

0.89

0.11

227

1469

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.56

8.58

3.0

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

439

3278

1.37

8.53

2.6

73.60

70.00

e9/l

1.17

330

2441

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

168

1032

1.65

8.51

1.4

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

970

8060

1.25

8.49

1.7

1.4

2.38

2.43

g/l

0.38

620

4926

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

267

2.30

8.47

3.2

2.5

553.12

533.60

e6/l

0.10

225

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.30

8.39

2.2

2.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

141

830

1.72

8.39

3.7

3.8

58.95

57.33

0.88

141

830

(3014111) Lactate [Moles/volume] in Serum or Plasma

471

3566

1.35

8.37

6.6

7.2

1.37

1.35

mmol/l

0.10

456

3473

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

136

798

1.72

8.19

1.3

1.9

0.85

0.83

nmol/l

0.10

109

678

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

328

2355

1.42

8.04

1.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

440

1.97

8.03

1.2

1.1

1.29

2.54

iu/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

842

1.69

7.98

5.0

6.0

509.68

589.77

iu/ml

0.09

115

(3003181) Sodium [Moles/volume] in Urine

120

685

1.77

7.97

1.5

1.4

62.13

65.15

mmol/l

0.29

548

(3048929) Epstein Barr virus Ab [Presence] in Serum

197

1279

1.56

7.96

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

120

686

1.77

7.93

2.1

1.9

4.86

4.96

mmol/24h

0.13

110

597

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

256

2.28

7.92

3.2

2.6

0.21

0.22

e9/l

0.04

222

(3036489) Thrombin time

236

1596

1.50

7.91

2.7

2.0

21.62

21.45

0.14

211

1401

(4146454) Self-monitoring of blood glucose

395

2.02

7.87

2.8

2.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

417

1.98

7.80

5.5

5.0

7.89

7.08

mmol/l

0.92

355

(3015171) Extractable nuclear Ab [Units/volume] in Serum

228

1536

1.51

7.79

1.2

0.38

1.13

u/ml

1.79

137

(3021901) Oxygen saturation in Capillary blood

120

694

1.75

7.64

3.5

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1271

10971

1.21

7.61

1.7

1.6

1.52

1.37

mmol/l

4.70

1050

9247

(3000060) B lymphocytes [#/volume] in Blood

107

3.00

7.60

3.3

2.0

97.50

175.71

e6/l

1.47

(3019060) Gas panel - Arterial blood

350

2569

1.39

7.57

6.5

5.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

637

5119

1.28

7.35

1.7

1.45

1.44

0.18

558

4551

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

222

1507

1.49

7.33

2.3

2.2

4087.02

5463.01

u/l

0.35

604

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

159

1003

1.60

7.30

1.8

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

720

1.71

7.25

1.6

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2971

27647

1.17

7.21

3.1

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1125

9652

1.21

7.12

4.1

3.5

—

(3047181) Lactate [Moles/volume] in Blood

186

1225

1.54

7.09

7.5

6.5

1.28

1.31

mmol/l

0.23

166

1072

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

183

1202

1.54

7.06

1.6

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

303

4113

0.72

7.02

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

189

1253

1.53

7.00

1.8

1.5

1.16

0.31

iu/ml

0.50

280

(3000991) Gas panel - Venous blood

438

3373

1.33

6.95

8.3

8.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.97

6.88

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

512

4035

1.30

6.87

2.5

2.4

124.13

39.03

u/l

0.46

448

3473

(3006245) CD3-CD19+ cells/100 cells in Blood

154

2.54

6.83

3.2

2.0

15.50

10.38

0.94

144

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

158

1012

1.58

6.83

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1399

1.48

6.63

2.3

2.2

2.75

2.97

g/l

2.74

179

1255

(3008037) Lactate [Moles/volume] in Venous blood

136

849

1.62

6.55

3.3

2.9

1.58

1.57

mmol/l

0.05

131

824

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

291

2124

1.39

6.54

8.2

9.9

24.07

24.31

mmol/l

0.67

282

2056

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1496

1.46

6.49

2.3

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1497

1.46

6.47

2.3

2.1

7.19

7.39

g/l

1.00

190

1352

(40767503) Oxygen content in Capillary blood by calculation

136

852

1.61

6.47

2.6

2.4

17.05

16.25

1.44

412

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

293

2148

1.39

6.42

9.8

10.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

320

2382

1.37

6.38

1.7

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

363

1.94

6.37

1.3

1.42

1.46

nmol/l

0.15

325

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

143

911

1.59

6.35

2.5

2.2

93.12

97.12

ug/min

0.06

556

(3021879) Hepatitis B virus core Ab [Presence] in Serum

416

3224

1.32

6.33

1.6

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1496

1.46

6.32

2.3

2.1

3.60

3.67

g/l

0.32

189

1352

(3004809) Band form neutrophils/100 leukocytes in Blood

108

642

1.70

6.30

3.9

3.6

1.18

1.65

1.06

566

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

202

1391

1.47

6.26

2.3

2.2

9.98

10.32

g/l

0.52

173

1238

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

359

1.93

6.23

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

359

1.93

6.23

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

359

1.93

6.23

1.4

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

430

1.85

6.22

1.4

1.5

68.79

58.50

1.54

273

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

773

6469

1.23

6.21

1.7

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

106

630

1.70

6.20

1.6

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

132

2.59

6.19

1.4

1.2

0.29

0.30

g/l

0.38

105

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.66

6.19

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

101

594

1.71

6.14

1.5

1.4

28.36

28.77

u/l

0.04

494

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

271

1977

1.39

6.13

5.0

4.1

23.93

24.12

mmol/l

0.49

265

1941

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

233

2.16

6.08

3.2

2.5

41.01

42.58

0.20

130

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

201

2.25

6.06

1.6

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

201

2.25

6.06

1.6

1.9

—

(3025941) Bacteria identified in Stool by Culture

307

2291

1.36

6.04

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

611

5001

1.25

6.02

7.8

6.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

200

1386

1.46

6.02

2.3

596.56

668.65

ug/l

0.10

186

1309

(40761536) Microorganisms panel - Urine sediment

462

3658

1.29

5.99

4.5

3.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

109

659

1.67

5.99

1.2

4.55

4.11

u/ml

0.08

214

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

133

847

1.59

5.94

1.7

1.4

31.30

19.35

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.68

5.91

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.68

5.91

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.29

5.85

1.2

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

225

1603

1.42

5.85

2.4

1.9

5.84

2.21

ug/l

0.88

196

1420

(3024980) IgG subclass 4 [Mass/volume] in Serum

110

674

1.65

5.76

1.5

1.6

0.64

0.76

g/l

0.78

513

(3017354) Segmented neutrophils/100 leukocytes in Blood

392

1.85

5.70

3.6

3.7

59.59

56.80

0.50

326

(3022145) Colonoscopy Study observation

560

4567

1.25

5.70

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

217

1545

1.42

5.67

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

338

2587

1.33

5.64

3.0

3.4

4.44

4.49

pmol/l

0.28

296

2302

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

131

843

1.57

5.62

1.8

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

159

1068

1.50

5.61

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

125

796

1.58

5.61

3.5

3.0

8.19

7.35

mmol/l

2.10

119

776

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

176

2.28

5.61

1.1

1544.63

1519.89

miu/ml

0.05

176

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

121

765

1.60

5.60

1.7

1.4

115.68

117.84

u/ml

0.07

155

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

164

1112

1.49

5.54

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

418

1.81

5.52

1.3

0.33

0.42

g/l

2.49

291

(3028192) IgG subclass 2 [Mass/volume] in Serum

418

1.81

5.52

1.3

2.19

2.95

g/l

5.04

292

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

171

1170

1.48

5.52

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.00

5.52

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

567

1.69

5.51

1.6

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

552

1.70

5.51

1.6

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

419

1.80

5.48

1.3

5.57

6.82

g/l

2.28

292

(3027923) C peptide [Moles/volume] in Serum or Plasma

191

2.21

5.46

1.7

1.4

1.30

1.18

nmol/l

0.25

150

(3021387) Prolactin [Units/volume] in Serum or Plasma

206

1466

1.42

5.41

1.8

1.6

298.80

298.56

mu/l

0.00

184

1322

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

105

647

1.64

5.40

1.1

101.89

15296.70

iu/ml

0.53

153

(3028271) Lactate [Moles/volume] in Capillary blood

104

640

1.64

5.38

1.8

1.73

1.67

mmol/l

0.31

104

623

(3037756) Immunofixation for Serum or Plasma

122

784

1.57

5.29

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

328

2525

1.32

5.27

1.3

193.98

214.58

u/ml

0.25

303

2328

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

197

2733

0.71

5.25

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

605

5026

1.23

5.20

2.4

2.3

155.55

135.49

ug/g

0.51

483

3993

(4035726) Immunohistochemistry procedure

468

3780

1.26

5.18

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

577

4774

1.23

5.16

2.8

6.94

8.56

umol/l

1.20

499

4139

(4062490) Immunoglobulin typing, IgG

420

1.77

5.16

1.4

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

277

1.96

5.14

1.1

—

(3016038) Potassium [Moles/volume] in Urine

250

2.01

5.12

1.2

37.02

35.28

mmol/l

0.23

225

(40761535) Cells panel - Urine sediment

410

3266

1.28

5.10

3.9

3.4

—

(3019225) pH of Specimen

490

3988

1.25

5.09

4.7

4.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

164

1133

1.46

5.07

2.3

2.1

0.05

0.03

g/l

0.32

148

1039

(3035637) Corticotropin [Mass/volume] in Plasma

498

1.70

5.03

1.3

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

420

3364

1.27

5.00

3.0

2.9

181.54

200.27

ng/l

0.47

372

3053

(3039000) Anion gap in Blood

130

861

1.52

4.95

9.1

7.7

11.40

11.36

mmol/l

0.05

121

763

(3018405) Lactate [Moles/volume] in Arterial blood

194

1390

1.41

4.94

5.0

3.8

1.36

1.38

mmol/l

0.10

188

1368

(3018572) Chloride [Moles/volume] in Blood

130

862

1.52

4.93

9.1

7.7

105.17

105.29

mmol/l

0.11

121

764

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

420

3371

1.27

4.92

3.0

2.5

64.24

66.58

ml/min/173m2

0.54

186

1307

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

130

865

1.52

4.85

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

182

1294

1.42

4.85

2.7

2.2

0.64

1.00

g/l

0.77

153

1112

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

101

635

1.60

4.84

1.2

3.56

4.23

u/ml

0.33

270

(3021788) Differential panel - Synovial fluid

108

690

1.58

4.83

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

135

907

1.50

4.82

1.7

1.6

15412.73

13976.11

e6/l

0.17

100

639

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.22

4.81

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

277

1.92

4.81

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

169

2.20

4.80

1.6

2.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

131

877

1.51

4.76

1.4

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

638

1.59

4.75

3.2

2.9

53577.40

1629.92

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

123

813

1.53

4.74

1.3

1.2

248.49

271.15

u/ml

0.40

495

(3052851) Hemolysis interference index of Serum or Plasma

176

1251

1.42

4.70

2.8

3.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

485

1.68

4.70

2.3

1.8

13328.00

826.67

titre

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

344

2709

1.29

4.70

1.2

—

(3020891) Body temperature

216

1596

1.37

4.60

6.0

4.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

130

877

1.49

4.57

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

209

1539

1.37

4.55

1.9

1.8

—

(3028433) Virus identified in Specimen by Culture

141

2.28

4.53

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

242

1.95

4.48

1.1

1.08

1.05

ratio

0.51

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1179

1.42

4.48

2.3

2.1

38.00

37.79

g/l

0.16

140

1033

(3003338) MCHC [Mass/volume]

3841

36964

1.14

4.46

22.0

17.1

332.25

332.49

g/l

0.82

3819

36671

(3006922) Hepatitis E virus Ab [Presence] in Serum

299

1.85

4.46

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

160

1130

1.43

4.45

1.4

286.78

282.99

ug/g

0.09

631

(3025018) Bordetella pertussis Ab [Titer] in Serum

229

1.97

4.43

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

561

4702

1.22

4.43

2.1

2.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

373

1.75

4.42

2.2

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

160

1132

1.43

4.41

1.2

144.44

113.91

titre

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.01

4.39

1.2

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

480

1.66

4.37

1.6

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

480

1.66

4.37

1.6

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

224

1680

1.35

4.36

2.1

1.9

—

(3017732) Neutrophils [#/volume] in Blood

354

2829

1.27

4.32

3.0

2.9

5.20

5.04

e9/l

0.07

273

2308

(3020961) Endomysium IgA Ab [Titer] in Serum

248

1891

1.33

4.32

1.1

52.50

167.34

titre

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

119

2.36

4.31

1.6

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

623

1.57

4.29

1.5

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

389

3147

1.25

4.29

2.3

2.1

12.21

12.88

nmol/l

0.77

341

2829

(3028707) Methadone [Presence] in Urine by Screen method

101

655

1.55

4.28

1.8

2.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

150

1057

1.43

4.24

2.4

2.1

0.00

g/l

-0.00

134

968

(3020876) Protein [Mass/time] in 24 hour Urine

432

1.68

4.19

2.2

2.4

1.36

1.39

g/24h

0.04

223

(3008295) Osmolality of Serum or Plasma

417

1.69

4.19

1.4

275.60

279.02

mosm/kgh2o

0.63

334

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

147

1041

1.42

4.06

2.4

2.1

0.00

g/l

-0.00

134

967

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

453

1.64

4.01

2.1

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.94

4.00

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

163

2.09

3.96

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

163

2.09

3.96

1.7

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

556

1.57

3.96

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

191

1422

1.36

3.93

1.8

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

250

1937

1.31

3.92

1.3

1.4

22.34

28.78

iu/l

2.51

199

1658

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

164

2.08

3.91

1.7

2.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

574

1.56

3.90

2.8

2.0

2.00

4.17

titre

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

128

893

1.44

3.86

1.5

1.4

—

(3023419) Bacteria identified in Sputum by Culture

568

1.56

3.85

2.6

—

(3022313) Gas panel - Capillary blood

233

1795

1.31

3.81

4.5

3.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

214

1.92

3.81

2.0

1.5

5.31

6.88

u/l

1.07

181

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.95

3.79

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

279

1.80

3.78

2.0

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

587

1.54

3.77

1.7

1.5

—

(1616796) Gas panel - Central venous blood

129

906

1.43

3.76

3.6

3.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

140

2.15

3.76

1.3

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

110

750

1.48

3.74

1.9

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

408

1.65

3.73

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

645

1.51

3.72

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

181

2.00

3.72

5.1

12.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

141

2.13

3.70

1.5

2.2

—

(3049717) Cytology report of Urine Cyto stain

196

1483

1.33

3.65

2.4

2.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

465

1.60

3.65

2.6

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

411

1.64

3.64

4.8

4.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

476

1.58

3.56

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

496

4200

1.20

3.55

2.0

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

637

1.50

3.53

1.1

12.38

12.18

au/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

446

1.60

3.52

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

171

1276

1.35

3.51

3.6

2.5

3.56

3.58

g/l

0.05

161

1210

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.16

3.50

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

100

679

1.48

3.50

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

126

895

1.42

3.48

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

111

771

1.45

3.46

1.6

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

173

1.97

3.42

1.2

1.3

164.29

156.90

mmol/24h

0.20

173

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

554

4755

1.18

3.41

1.6

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

472

3998

1.20

3.38

1.8

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

320

1.69

3.36

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

203

1564

1.31

3.36

4.6

3.7

24.76

24.86

mmol/l

0.21

191

1431

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

491

1.56

3.36

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

628

1.49

3.35

1.1

121.57

115.24

1.12

577

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

793

1.43

3.35

1.2

1.31

4.15

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

492

1.55

3.33

1.3

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

695

1.46

3.32

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

477

1.56

3.31

2.6

2.2

4.03

4.07

mmol/l

0.39

471

(3035285) Chloride [Moles/volume] in Venous blood

477

1.56

3.31

2.6

2.2

105.39

105.40

mmol/l

0.01

471

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

247

1.79

3.31

1.3

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

162

1212

1.35

3.29

3.6

3.4

108.13

51.00

mg/l

0.33

125

967

(3025468) Yersinia sp identified in Specimen by Organism specific culture

486

1.55

3.28

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

200

1544

1.31

3.27

1.8

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

158

1179

1.35

3.27

3.4

3.3

1.01

1.70

ratio

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

162

1214

1.35

3.26

3.5

3.4

38.28

102.98

mg/l

0.76

125

969

(3010375) cycloSPORINE [Mass/volume] in Blood

205

1.86

3.24

23.9

25.8

110.20

115.40

ug/l

0.24

169

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

256

1.76

3.24

1.0

1.1

8.94

8.75

iu/ml

0.02

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

488

1.54

3.23

1.3

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.67

3.22

1.4

1.7

194.25

118.99

ng/l

0.42

(3028300) Cannabinoids [Presence] in Urine

200

1548

1.30

3.22

1.8

2.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

489

1.54

3.20

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

196

1515

1.31

3.19

1.8

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

499

1.53

3.15

1.3

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

396

1.60

3.15

1.9

2.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

187

1.88

3.09

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

253

1.75

3.08

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

291

1.69

3.06

2.4

2.2

719.03

612.75

0.94

195

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

112

2.15

3.05

2.3

2.8

26.42

29.01

umol/l

0.47

(3037121) Protein [Mass/volume] in Urine

178

1368

1.31

3.04

3.8

3.3

0.35

0.29

g/l

0.45

597

(36660697) Celiac disease serology panel - Serum

389

3271

1.20

3.03

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

3.01

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

125

912

1.38

3.01

3.6

3.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

371

1.60

2.97

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

190

1.85

2.96

1.1

2.00

8.75

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1442

13338

1.11

2.93

5.0

4.7

2.52

3.43

ug/l

1.22

1286

11994

(3003327) Ova and parasites identified in Stool by Light microscopy

171

1315

1.31

2.92

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

177

1.87

2.90

1.3

1.4

4.78

4.21

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.44

2.89

1.2

1.1

—

(40768443) Skin Pathology biopsy report

226

1804

1.26

2.89

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

122

895

1.37

2.86

2.1

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

503

1.50

2.85

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

143

1.96

2.84

1.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

174

1347

1.30

2.84

3.3

2.2

91.88

91.41

0.11

168

1301

(3002256) Pathology report gross observation

636

5606

1.15

2.82

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

117

855

1.38

2.81

3.3

2.9

33.90

35.55

umol/l

0.28

105

774

(3000764) Benzodiazepines [Presence] in Urine

195

1535

1.28

2.80

1.8

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

135

1010

1.35

2.80

4.5

4.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

481

1.50

2.79

1.3

1.4

313.38

324.23

pmol/l

0.08

417

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

194

1.81

2.79

1.1

3.2

—

(3011985) Renin [Units/volume] in Plasma

523

1.48

2.76

1.4

1.5

55.32

52.54

mu/l

0.07

465

(44813793) Dust mix specific IgE antibody measurement

285

1.65

2.75

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

484

1.49

2.72

1.2

1.3

—

nmol/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

174

1.84

2.71

1.9

3.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

125

2.00

2.70

1.2

1.5

82.64

145.03

nmol/24h

0.64

125

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.22

2.67

1.1

—

(3011288) Drugs identified in Urine by Screen method

137

1036

1.33

2.66

2.8

3.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

154

1.89

2.65

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

112

822

1.37

2.64

1.2

24.19

34.25

u/ml

0.40

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

177

1388

1.28

2.64

3.0

3.2

0.38

0.33

u/ml

1.02

794

(1001926) Buprenorphine [Presence] in Urine by Screen method

156

1204

1.30

2.63

1.7

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

337

1.58

2.59

1.5

1.4

23.72

29.84

0.61

197

(3042631) Mycobacterium sp identified in Specimen

540

1.45

2.57

2.4

2.8

—

(3024928) Oxygen saturation in Venous blood

117

870

1.35

2.55

3.9

3.1

—

(3012565) Volume of 24 hour Urine

215

1.73

2.55

2.2

2.3

1976.25

1875.00

0.26

195

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

307

1.60

2.55

1.9

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

224

1816

1.24

2.54

1.9

1.7

1.55

1.54

g/l

0.08

194

1563

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

336

2838

1.20

2.54

1.1

1.2

184.80

154.65

iu/ml

0.54

125

1050

(3024891) Influenza virus A+B Ag [Presence] in Specimen

145

1114

1.31

2.54

1.2

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

246

1.67

2.52

10.5

11.6

0.62

mmol/l

0.02

224

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

157

1221

1.29

2.51

1.7

42.33

41.89

nmol/l

0.07

150

1185

(3013727) Leukocytes other/100 leukocytes in Blood

129

1.94

2.49

5.7

3.3

49.88

53.73

0.34

124

(3010421) pH of Blood

143

1105

1.30

2.42

3.5

4.3

7.42

0.07

128

1007

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

145

1.87

2.41

3.0

2.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

103

2.04

2.41

1.4

1.2

44.06

39.68

g/l

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

556

1.43

2.41

1.3

0.12

0.31

nmol/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.34

2.39

1.9

1.6

2.28

2.43

mg/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

146

1.85

2.36

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

256

2125

1.22

2.35

2.5

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

131

1005

1.31

2.34

1.2

1.3

3.04

7.11

u/ml

1.55

155

(3044941) Cell count panel - Synovial fluid

603

1.40

2.30

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

276

1.60

2.30

1.4

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.22

2.30

1.2

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

567

5033

1.14

2.30

5.0

4.3

31.61

32.41

0.96

400

3427

(3036180) Methadone [Presence] in Urine

170

1.77

2.28

1.5

3.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.23

2.27

1.0

1.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.56

2.27

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

505

1.43

2.25

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

350

1.52

2.24

1.2

1.1

381.62

370.27

nmol/l

0.15

300

(3010144) Erythrocytes [#/volume] in Synovial fluid

342

1.53

2.23

1.5

1.3

50325.21

86200.09

e6/l

0.40

233

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

129

997

1.30

2.21

1.2

1.83

6.41

u/ml

0.74

(3022621) pH of Urine by Test strip

314

2674

1.19

2.21

3.2

2.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1151

10666

1.10

2.20

4.1

23.00

21.82

1.74

548

5097

(3045142) Bone marrow Pathology biopsy report

475

1.44

2.19

1.2

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

475

1.44

2.19

2.7

2.1

35.13

20.67

mg/l

0.89

120

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

475

1.44

2.19

1.1

95.76

95.35

0.05

451

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.34

2.18

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

875

0.69

2.16

2.0

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

305

1.55

2.15

1.0

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

460

1.44

2.15

1.2

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

306

1.54

2.13

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

306

1.54

2.13

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

189

1.70

2.13

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

189

1.70

2.13

1.3

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

854

7813

1.11

2.10

2.9

0.82

0.76

ug/l

0.43

562

5099

(3012501) Base excess in Blood by calculation

122

943

1.30

2.10

3.7

4.4

2.24

2.67

mmol/l

1.07

632

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1.54

2.10

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.00

2.10

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.00

2.10

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.00

2.10

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.00

2.10

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

109

1.93

2.10

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.20

2.09

1.1

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

259

2180

1.20

2.09

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

175

1.72

2.09

1.2

1.6

3.08

6.91

nmol/l

0.65

136

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

308

1.53

2.07

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

308

1.53

2.07

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

308

1.53

2.07

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.26

2.07

1.3

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.00

2.07

1.4

1.3

821.40

467.52

nmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

333

1.51

2.05

1.1

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

261

1.58

2.05

1.6

1.4

19.70

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

262

1.57

2.02

5.9

6.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

392

1.46

2.01

4.7

4.9

128.92

64.66

u/ml

0.32

112

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.08

2.01

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.82

2.00

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

144

1147

1.26

1.98

4.8

3.5

1.57

1.50

mg/l

0.47

127

1056

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.28

1.97

1.7

2.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

217

1.62

1.96

9.7

5.6

39.17

735.92

u/ml

0.55

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

631

1.35

1.95

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

135

1.78

1.90

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

181

1.66

1.88

1.1

90.72

94.84

0.29

146

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.09

1.86

2.1

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.03

1.85

1.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.53

1.83

5.0

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

115

1.83

1.82

3.5

3.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

755

1.30

1.78

1.5

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

547

1.36

1.78

1.9

1.8

89.11

89.61

0.22

539

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

146

1.72

1.77

2.2

3.2

6.69

7.98

mg/l

0.65

120

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

463

1.39

1.75

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.74

11.7

9.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

162

1.67

1.74

1.7

2.3

93.00

184.65

umol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

749

1.30

1.74

1.6

1.5

—

(3014271) Vancomycin [Susceptibility]

201

1.60

1.73

2.7

2.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

125

1.76

1.71

1.5

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

165

1360

1.22

1.71

1.4

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

282

1.49

1.71

1.3

1.2

72.00

49.20

u/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

218

1.56

1.70

1.3

1.2

—

(3004451) EKG impression Narrative

187

1.61

1.68

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

187

1.61

1.68

6.2

3.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

284

1.48

1.66

1.3

1.2

41.00

40.61

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

702

1.30

1.66

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

188

1.60

1.65

1.6

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

486

1.36

1.64

2.3

2.4

—

(3008898) HLA-B27 [Presence]

169

1409

1.21

1.58

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.00

1.58

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

144

1.67

1.57

1.2

2.2

174.33

169.02

0.10

137

(3032057) Clostridioides difficile [Presence] in Stool

1.93

1.54

1.1

2.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.43

1.53

1.1

1.2

4.88

20.12

u/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

109

871

1.26

1.53

1.7

1.9

201.25

201.40

pmol/l

0.01

102

825

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

138

1.67

1.51

1.1

1.2

94.89

87.13

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

138

1.67

1.51

1.1

94.22

88.64

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.86

1.50

1.0

1.2

302.18

283.89

pmol/l

0.10

(3047007) Chlamydophila sp Ab [Presence] in Serum

573

1.31

1.49

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

608

1.30

1.49

1.3

1.4

0.26

0.40

nmol/l

1.71

476

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.00

1.48

4.7

5.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

259

1.47

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

259

1.47

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.22

1.46

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.37

1.45

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

228

0.53

1.44

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.31

1.43

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

311

1.42

1.1

1.2

80.00

205.74

titre

—

(3025130) Human papilloma virus identified in Specimen

572

1.30

1.38

1.5

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.80

1.37

1.4

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.61

1.36

1.5

2.0

2.45

3.20

mg/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

135

1121

1.21

1.36

1.1

15.96

5.81

u/ml

0.36

152

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.76

1.34

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.14

1.33

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.91

1.33

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

488

1.32

2.0

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

700

1.26

1.32

1.7

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

298

2647

1.13

1.30

2.3

1.9

—

(3016750) Collection duration of Urine

209

1.49

1.29

2.5

2.2

522.63

485.62

min

1.27

156

(3006653) Thiamine [Moles/volume] in Blood

193

1.51

1.29

1.8

1.3

124.93

135.56

nmol/l

0.81

193

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

473

1.31

1.28

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.89

1.28

4.5

6.7

—

(4200892) Spirometry reversibility

313

2793

1.13

1.27

1.5

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.72

1.27

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.05

1.26

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

1.68

1.25

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.82

1.25

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

1059

1.20

1.25

1.7

1.9

6.01

4.46

iu/l

0.56

406

(3017509) Phencyclidine [Presence] in Urine

2.22

1.24

1.1

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

187

1.50

1.23

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

139

1.59

1.23

2.0

2.6

262.54

157.21

au/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

673

1.25

1.21

1.4

1.2

28.69

46.09

u/l

1.12

580

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.80

1.21

1.7

2.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

102

1.67

1.16

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

257

1.40

1.15

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

232

1.43

1.14

1.2

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

222

0.58

1.13

1.2

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

378

1.33

1.13

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

1.60

1.11

1.4

1.5

9.81

8.86

ug/l

0.38

119

(3045414) Leukocytes [Presence] in Urine

210

1846

1.14

1.11

1.8

1.9

—

(3020491) Glucose [Moles/volume] in Blood

293

1.37

1.11

2.5

2.2

6.68

6.55

mmol/l

0.14

199

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

293

1.37

1.11

1.9

2.0

1.06

1.63

u/field

0.82

115

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.96

1.11

1.5

1.3

—

(3014891) Appearance of Pleural fluid

1.96

1.11

1.4

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

340

0.68

1.09

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

449

4129

1.10

1.08

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

252

1.39

1.08

1.0

1.1

0.16

2.86

u/ml

1.04

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

152

1309

1.17

1.07

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

194

1.45

1.06

2.4

—

(40768446) Kidney Pathology biopsy report

161

1.49

1.06

2.0

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

322

1.34

1.05

1.9

1.3

1.14

1.26

promille

0.24

249

(3000330) Specific gravity of Urine by Test strip

230

2043

1.13

1.05

3.9

3.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

340

1.33

1.04

2.0

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

410

1.30

1.04

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

419

1.29

1.04

1.2

43.52

61.13

u/l

3.53

370

(4034850) Laboratory test

156

1351

1.16

1.03

10.1

8.8

—

(3028717) Thiamine [Mass/volume] in Blood

2.06

1.02

1.0

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

204

1.42

1.02

2.0

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.74

1.02

1.7

2.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

106

1.61

1.02

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

196

1.43

1.02

2.0

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

196

1.43

1.02

2.0

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

106

891

1.19

1.01

1.4

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

755

1.21

0.99

2.8

3.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

396

1.29

0.99

2.3

2.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.84

0.98

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

593

1.23

0.98

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

0.98

3.4

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.17

0.98

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

266

1.36

0.97

2.0

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

725

6833

1.07

0.96

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

424

1.28

0.96

2.9

3.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

514

1.25

0.95

1.7

1.4

3.09

3.93

ug/l

0.60

460

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.61

0.93

1.1

1.3

14.25

33.00

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

192

1.41

0.92

1.7

1.33

3.39

u/field

1.10

142

(3003694) ABO and Rh group [Type] in Blood

1263

12141

1.05

0.88

1.4

1.5

—

(3019977) pH of Arterial blood

220

1.37

0.87

2.5

2.7

7.41

7.42

0.36

(3006462) Nitrate [Presence] in Urine

186

1.40

0.87

3.6

3.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.00

0.87

1.2

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

0.87

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

148

1299

1.14

0.86

1.3

232.46

224.36

miu/ml

0.10

609

(1002224) Polysomnography panel

201

1800

1.12

0.85

1.1

—

(3019174) dRVVT (LA screen)

1.94

0.84

1.2

1.3

—

(3024932) HLA-DR beta [Type]

137

1.46

0.84

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

461

4301

1.08

0.83

3.5

4.1

11.33

24.00

ug/l

1.30

380

3460

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

283

1.31

0.83

1.0

718.27

729.73

ng/l

0.06

191

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

231

2089

1.11

0.83

2.3

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.74

0.82

1.1

1.0

—

(3024471) HLA-A [Type]

138

1.45

0.81

1.0

—

(3045424) Erythrocytes [Presence] in Urine

682

1.19

0.80

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

285

1.30

0.80

1.0

41.06

43.94

ng/l

0.20

194

(3035320) C reactive protein [Mass/volume] in Body fluid

294

1.29

0.79

3.0

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

212

2344

0.90

0.79

1.6

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

902

0.84

0.79

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

474

1.23

0.78

1.3

1.4

3324.05

2345.71

e6/l

0.36

336

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

295

1.29

0.78

2.0

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.77

0.0

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.70

0.75

12.3

9.5

7.39

5.81

mmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

0.74

1.4

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.08

0.74

3.4

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.74

1.0

1.5

—

(40768800) Prostate Pathology biopsy report

842

0.84

0.74

1.2

—

(3042517) Benzodiazepines panel - Urine

1.84

0.73

2.0

2.2

—

(40768795) Lymph node Pathology biopsy report

415

1.23

0.73

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

100

1.50

0.72

1.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.80

0.72

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

134

1.42

0.71

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

212

1.32

0.70

1.2

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.51

0.69

1.1

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

283

1.27

0.69

1.0

318.52

324.87

ng/l

0.07

196

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

1.44

0.69

2.3

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

1.44

0.69

2.3

2.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.67

0.68

2.3

2.5

—

(3045788) Cell count panel - Pleural fluid

374

1.23

0.67

1.3

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.54

0.65

1.0

1.1

0.73

0.70

umol/24h

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.72

0.64

1.2

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

131

1464

0.89

0.63

1.9

—

(3042733) HLA Ab [Presence] in Serum

146

1.37

0.63

4.8

—

(3005033) Fetal Nuchal fold Thickness US

870

0.86

0.63

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

516

1.18

0.62

1.9

2.1

6.12

7.91

umol/l

0.55

369

(3032868) Hemoglobin electrophoresis panel in Blood

1.63

0.62

1.1

1.4

—

(3024263) Appearance of Synovial fluid

208

1.30

0.61

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.67

0.61

1.4

1.5

271.20

378.57

umol/24h

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

244

1.27

0.61

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

131

1174

1.12

0.61

1.3

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

253

1.27

0.61

1.0

1.1

0.29

1.04

u/ml

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.57

0.60

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.60

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1530

15704

0.96

0.60

3.0

2.7

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

245

1.27

0.59

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.54

0.59

1.1

—

(3000012) Reticulocyte production index

556

1.17

0.59

1.8

2.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.51

0.58

1.1

1.2

—

(40768441) Liver Pathology biopsy report

327

1.22

0.58

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

873

0.87

0.58

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.56

1.3

1.7

36.83

40.56

umol/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.56

4.3

2.7

0.33

0.67

u/field

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

429

1.19

0.56

1.3

1.4

65815.87

80308.58

e6/l

0.14

245

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.51

0.56

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

203

1.28

0.55

2.0

98.80

231.35

ug/min

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

843

1.13

0.54

1.1

1.28

2.26

u/ml

0.77

416

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

114

1023

1.12

0.54

2.2

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

286

1.23

0.52

1.3

0.49

1.07

u/ml

0.69

153

(3017704) Immunofixation for Urine

196

1.28

0.52

1.3

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

102

1138

0.89

0.51

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

100

0.60

0.51

3.5

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

100

0.60

0.51

7.0

6.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

179

1.29

0.51

2.3

2.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.39

0.50

1.1

1.0

94.23

79.13

ug/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

585

0.85

0.50

1.4

1.3

7.32

7.22

mmol/l

0.10

519

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

270

1.22

0.49

1.5

—

(21494755) Public health laboratory ask at order entry panel

419

4404

0.95

0.49

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

173

1.27

0.46

5.2

5.7

56.73

62.67

mg/l

0.20

122

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

183

1.26

0.44

2.4

56.74

51.93

umol/l

0.21

157

(3003129) Base excess in Capillary blood by calculation

1.40

0.44

1.2

1.9

1.44

1.01

mmol/l

0.18

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.45

0.44

3.1

3.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.37

0.43

6.3

7.5

—

(3012441) Differential panel - Pleural fluid

414

1.16

0.43

1.3

1.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.61

0.43

1.0

1.1

—

41.81

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

129

1185

1.09

0.42

1.3

1.1

—

(4281824) Cell count and differential, peritoneal fluid

457

0.85

0.42

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

221

2076

1.07

0.41

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

240

1.21

0.41

2.3

1.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.07

—

(3050794) Legionella sp Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

282

0.81

0.40

1.1

1.3

1.49

1.57

g/l

0.82

282

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.33

0.40

1.4

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

893

1.10

0.39

4.3

3.2

23.85

26.77

mg/l

0.31

549

(3044007) Cell count panel - Peritoneal fluid

124

1.29

0.38

1.3

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

628

1.12

0.37

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

129

1194

1.08

0.37

1.3

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.37

1.0

1.1

2.78

1.67

umol/24h

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.39

0.36

1.3

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

116

0.69

0.36

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.36

0.36

1.5

1.3

—

(3044927) Protein electrophoresis panel - Urine

356

1.15

0.36

1.1

1.2

—

(3051651) Icteric interference index of Serum or Plasma

263

1.18

0.35

3.3

3.6

—

(3000034) Microalbumin [Mass/volume] in Urine

366

1.15

0.35

4.0

3.2

74.85

53.84

mg/l

0.22

278

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

138

1481

0.93

0.35

1.5

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

222

0.81

0.34

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.34

0.34

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

237

1.18

0.33

2.3

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

109

1.29

0.33

6.9

7.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

220

1.18

0.31

1.0

0.78

1.87

u/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

608

1.10

0.31

4.9

5.2

389.68

364.80

umol/l

0.71

519

(3000492) Spirometry study

430

4153

1.04

0.31

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

103

955

1.08

0.31

1.5

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

667

1.10

0.30

1.1

—

(21494434) Karyotype in Bone marrow

372

1.13

0.29

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

278

1.15

0.29

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

669

1.09

0.29

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

106

1137

0.93

0.29

1.4

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

173

0.81

0.28

2.1

2.5

247.79

154.59

nmol/l

0.52

150

(3000919) Neutrophils/100 leukocytes in Pleural fluid

112

1.25

0.28

1.1

1.4

19.50

22.16

0.13

103

(40765089) Chromosome analysis panel - Blood by G-banded

112

1.25

0.28

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

329

1.13

0.25

1.6

1.4

144.81

195.00

pmol/l

0.92

329

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.22

0.25

2.0

20.17

16.54

umol/l

—

(3014051) Protein [Presence] in Urine by Test strip

116

1092

1.06

0.25

2.7

2.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

734

1.08

0.24

1.8

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

571

1.09

0.23

1.7

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

690

1.07

0.22

1.0

1.1

0.91

1.58

u/ml

0.52

335

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

10.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

10.2

—

60.60

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

1.95

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

11541.60

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.8

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.20

0.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

762

1.06

0.19

1.0

1.1

5.47

5.69

u/ml

0.04

387

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.21

0.19

1.5

0.45

0.41

ug/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

118

1.19

0.19

1.3

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1043

0.95

0.18

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1042

0.95

0.18

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

590

1.07

0.18

1.1

3.85

3.14

u/ml

0.21

286

(3012494) Peanut IgE Ab [Units/volume] in Serum

119

1.18

0.17

1.0

1.1

0.34

10.24

u/ml

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1040

0.95

0.17

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

552

1.07

0.17

1.0

1.1

3.78

4.10

u/ml

0.05

214

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.16

0.16

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.16

0.16

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.16

0.16

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.13

0.16

6.1

7.4

—

(40757373) Influenza virus identified in Isolate

1.21

0.15

1.8

1.7

—

(3048879) Bone marrow aspiration report

119

0.84

0.15

1.8

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

159

1.13

0.15

1.0

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

150

1.13

0.14

1.3

2.2

1715.42

655.40

e6/l

0.43

108

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

100

1043

0.96

0.14

1.3

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

160

1.13

0.14

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

843

1.04

0.13

1.8

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

191

1.10

0.11

1.2

—

(40765096) Chromosome analysis panel by Banding

124

1.13

0.11

1.3

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

157

0.89

0.11

1.6

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.16

0.11

1.1

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

161

1569

1.03

0.11

2.3

1.7

5.16

4.29

mg/l

0.28

126

1127

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

223

2185

1.02

0.10

3.3

3.5

44.50

56.64

u/ml

0.58

210

2107

(3015183) Erythrocyte sedimentation rate

212

1.09

0.10

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

125

0.88

0.10

1.4

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.14

0.10

1.8

2.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.06

0.09

1.4

1.1

—

(40768806) Pleura Pathology biopsy report

432

0.95

0.09

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

593

0.96

0.08

1.0

1.1

6.33

3.48

u/ml

0.39

269

(3008401) Mugwort IgE Ab [Units/volume] in Serum

735

1.03

0.08

1.0

1.1

2.14

1.26

u/ml

0.54

306

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.83

0.08

3.6

2.4

56.12

73.53

pmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

866

0.97

0.08

2.9

3.6

34.23

690.90

u/ml

1.50

792

(3036071) Salmonella sp Ab [Titer] in Serum

154

0.91

0.08

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

588

1.04

0.08

2.5

2.6

2843.54

484.40

u/ml

0.39

578

(3005011) Chlamydia sp Ab [Titer] in Serum

0.86

0.07

1.7

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

152

1491

1.02

0.07

2.5

3.5

102.16

3760.89

u/ml

1.23

123

1264

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

386

0.96

0.06

1.1

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

557

0.97

0.05

2.4

2.7

13.23

13.12

0.39

550

(40768793) Breast Pathology biopsy report

960

0.98

0.05

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

257

1.05

0.05

1.4

1.6

7.16

5.98

u/l

0.26

209

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

743

1.02

0.05

1.4

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

763

1.02

0.05

3.6

3.1

0.75

0.80

nmol/l

0.67

580

(3035933) Granulocytes/100 leukocytes in Blood

130

1.08

0.04

1.1

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

126

1278

0.99

0.04

1.5

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

101

1.09

0.04

4.5

3.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

131

1.07

0.03

2.5

2.1

7.96

9.59

mg/l

—

105

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

102

1.08

0.03

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

400

1.03

0.02

2.8

3.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

450

0.98

0.02

1.2

—

(3034426) Prothrombin time (PT)

162

1.05

0.02

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

196

1950

1.01

0.01

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

136

0.96

0.00

1.1

1.9

4567.62

22631.47

e6/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.05

0.00

1.5

1.3

—

(3033799) Differential panel - Peritoneal fluid

135

0.96

0.00

1.2

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

185

0.97

0.00

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

134

0.97

0.00

1.6

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

196

1.02

0.00

3.7

4.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

133

0.98

0.00

1.8

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

484

0.99

0.00

1.0

0.58

0.33

u/ml

—

130

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

337

1.01

0.00

1.5

0.90

0.96

g/l

0.59

337

(3020650) Glucose [Presence] in Urine

131

0.99

0.00

1.5

1.4

—

(3035880) pH of Pleural fluid

219

1.00

0.00

1.2

1.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

66.12

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.00

0.00

2.8

9.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.50

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.00

0.00

1.4

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.89

0.00

2.0

1.6

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.14

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.91

-0.00

1.0

1.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.3

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

2940.83

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

110

1.00

-0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_BELLPA and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_BELLPA	1.24 [1.13, 1.36]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.21

During the follow-up period (1.1.1998 — 31.12.2019), 2774 out of 16681 females with G6_BELLPA died.

Males

Parameter	HR [95% CI]	p-value
G6_BELLPA	1.149 [1.05, 1.26]	0.004
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 2668 out of 15120 males with G6_BELLPA died.

Mortality risk

Mortality risk for people of age

years, who have G6_BELLPA.

N-year risk	Females	Males
1	0.126%	0.226%
5	0.737%	1.389%
10	1.735%	3.341%
15	3.486%	6.307%
20	5.89%	10.913%

Relationships between endpoints

↥

Index endpoint: G6_BELLPA – Bell's palsy

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bell's palsy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints